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African Americans are disproportionately affected by diabetes mellitus (DM) and 
complications that include diabetic retinopathy and its disease and socioeconomic 
burdens. This study examined the relationships between diabetic retinopathy and health 
care utilization factors, such as gender, DM comorbidities of hypertension and 
hyperlipidemia, and health care access, among sampled African Americans with DM in 
the United States. The Andersen health care utilization model was the framework for the 
study. In this correlational cross-sectional study, data from the 2011-2016 National 
Health and Nutrition Examination Survey datasets were analyzed. Results of complex 
samples logistic regression showed that there were no significant associations between 
diabetic retinopathy and DM comorbidities of hypertension and hyperlipidemia, gender, 
and health care access, after controlling for hemoglobin A1C level, urine albumin-to-
creatinine ratio (UACR), marital status, education level, and annual household income. 
UACR, annual household income, and adult education level were significantly associated 
with diabetic retinopathy (p <.005). Researchers might use findings from this study for 
further studies to establish cause-and-effect relationships between diabetic retinopathy 
and the related health utilization factors in this population. Positive social change might 
be effected by using results from the study in planning and developing effective public 
health interventions targeting specific African American populations, which might result 
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Section 1: Foundation of the Study and Literature Review 
Introduction 
Diabetes mellitus (DM) is a disorder of metabolism characterized by chronic 
hyperglycemia due to defective insulin action, secretion, or both (American Diabetes 
Association [ADA], 2018; Chawla, Chawla, & Jaggi, 2016; World Health Organization 
[WHO], 2018). DM is commonly classified as Type 1 (T1DM) and Type 2 (T2DM) 
based on age and insulin requirements, with T1DM patients requiring insulin for sugar 
control and T2DM patients usually managed with lifestyle modification and oral 
medications, though parenteral insulin administration may be required for some cases 
(ADA, 2018; Punthakee, Goldenberg, & Katz, 2018; Shields et al., 2015; Skyler et al., 
2017; Yan, Li, Qin, Mayberry, & Daniels, 2018). T1DM results from defective insulin 
secretion, whereas T2DM, the most prevalent type of DM globally, is usually seen in 
adults and occurs due to insulin resistance or decreased insulin secretion (ADA, 2018; 
WHO, 2018). A common clinical feature of DM, irrespective of its type, is chronic 
hyperglycemia that results from defective insulin secretion, insulin resistance, or both, 
which leads to continuous hyperglycemia and increasing insufficiency of insulin with 
time (ADA, 2018; Chawla et al., 2016; Okur, Karantas, & Siafaka, 2017; Punthakee et 
al., 2018; Shields et al., 2015; Skyler et al., 2017; Zaccardi, Webb, Yates, & Davies, 
2016). Etiologic factors for DM pathophysiology (defective insulin secretion, insulin 
resistance or both, with resultant hyperglycemia) include genetics, age, race and 
ethnicity, gender, hyperlipidemia, hypertension, unhealthy diet, sedentary lifestyle, 
overweight and obesity, smoking, alcohol use, and socioeconomic status (ADA, 2018; 
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Baynes, 2015; Centers for Disease Control and Prevention [CDC], 2017; Skyler et al., 
2017).  
Uncontrolled DM, irrespective of its type, can lead to macrovascular (large 
vessel) disease affecting the heart and arteries, and microvascular (small vessel) disease 
affecting the eyes, kidneys and nerves (Beckman & Creager, 2016; Chawla et al., 2016; 
Ozawa, Bearse, & Adams, 2015; Solomon et al., 2017; WHO, 2018). DM is associated 
with concordant comorbidities, such as hypertension and hyperlipidemia, that are major 
intermediate factors in the development of macro- and microvascular diseases 
(Abdulghani, et al., 2018; Atchison & Barkmeier, 2016; Beckman & Creager, 2016; 
Cheng et al., 2014; Klimek, Kautzky-Willer, Chmiel, Schiller-Frühwirth, & Thurner, 
2015; Lin, Kent, Winn, Cohen, & Neumann, 2015; Magnan et al., 2015; Mozaffarian et 
al., 2016; Pantalone et al., 2015; Romero-Aroca et al., 2016; Rosiek et al., 2016; Solomon 
et al., 2017; Wat, Wong, & Wong, 2016; Zhuo et al., 2014).  
DM is currently diagnosed in about 23.1 million adults in the United States; 90% 
to 95% of adults living with diabetes have Type 2 DM (CDC, 2017b). Adult African 
Americans are disproportionately affected by DM, with a total percentage of 13.4% 
compared to 7.4% among Whites (ADA, 2018; CDC, 2017b). There was an increase in 
the prevalence of coexisting diabetes, hypertension, and hypercholesterolemia among 
U.S. adults from 3% in 1999–2000 to 6.3% in 2011–2012; higher among African 
Americans (10.2%), compared to Mexican Americans (6.1 %), other Hispanics (6.6%), 
Whites (5.6%), and 7.3% among other racial and ethnic groups  (Song et al., 2016). DM 
concordant comorbidities, such as hypertension and hyperlipidemia, are major 
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intermediate factors underlying cardiovascular disease such as diabetic retinopathy 
disparities of African-American populations (Beckman & Creager, 2016; Lin et al., 2015; 
Magnan et al., 2015; Mozaffarian et al., 2016; Pantalone et al., 2015; Rosiek et al., 2016; 
WHO, 2018; Zhuo et al., 2014). Chronic complications of diabetes, hyperlipidemia, and 
hypertension are associated with increased physical, mental, and socioeconomic burdens 
on populations, especially African Americans, who are disproportionately affected (Lang, 
& Marković, 2016; Lin et al., 2015).  
Diabetic retinopathy occurs when chronic high levels of blood glucose cause 
damage to blood vessels in the retina, which can lead to (a) swelling and leaking, or (b) 
closure of the retinal blood vessels that can prevent passage of blood through the blocked 
vessels, and (c) new blood vessel formation in the retina (American Academy of 
Ophthalmology, 2018b). It is separated into two main stages that include non-
proliferative diabetic retinopathy in the early stage, which may be symptomless, and 
proliferative diabetic retinopathy in the late and more advanced stage that may be vision-
threatening (American Academy of Ophthalmology, 2018b). Diabetic retinopathy is a 
significant cause of preventable eye damage that includes blindness; each year, between 
12,000 and 24,000 new cases of blindness are caused by diabetes retinopathy (Skaggs et 
al., 2017). 
Between 2005 and 2008, the prevalence of non-vision-threatening diabetic 
retinopathy and that of vision-threatening diabetic retinopathy among adults 40 years and 
older in the United States was 28.5 % and 4.4%, respectively (Zhang et al., 2010). 
African American populations are disproportionately affected by diabetic retinopathy 
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with a higher crude prevalence of 38.8% compared to 26.4% among Whites, and a higher 
vision-threatening retinopathy crude prevalence of 9.3% compared to 3.2% among 
Whites (CDC, 2017a; Zhang et al., 2010). Duration of diabetes, uncontrolled 
hyperglycemia, and hypertension are common important risk factors for the progression 
of diabetic retinopathy to vision-threatening diabetic retinopathy or loss of vision; 
glycemic and blood pressure control are effective in preventing diabetic retinopathy-
related loss of vision (Chen et al., 2014; Chew et al., 2010; Do et al., 2015; Lee, Wong, & 
Sabanayagam, 2015; Lima, Cavalieri, Lima, Nazario, & Lima, 2016; Mendanha, 
Abrahão, Vilar, & Nassaralla, 2016; Romero-Aroca et al., 2016; Ting, Cheung, & Wong, 
2016; Wat et al., 2016). Longer duration of diabetes, uncontrolled hyperglycemia, 
hypertension, and dyslipidemia are associated with diabetic retinopathy in African 
Americans (Papavasileiou et al., 2017; Penman et al., 2016).  
Diabetic retinopathy, including its vision-threatening type, is preventable by strict 
blood sugar control, control of concordant comorbid conditions (hypertension and 
hyperlipidemia), early detection through regular eye-screening of patients with DM, and 
prompt management of diabetic retinopathy (ADA, 2018; Chew et al., 2014; Do et al., 
2015; Rosiek et al., 2016; Yu et al., 2015). However, achieving tight control of blood 
sugar, hypertension, and hyperlipidemia; early detection through regular eye-screening of 
patients with DM; and prompt management of diabetic retinopathy depend on health care 
access (ADA, 2018; Chew et al., 2014; Do et al., 2015; Rosiek et al., 2016; Yu et al., 
2015). Strict glycemic control and control of concordant comorbidities depend on self-
management skills and activities such as medication adherence, self-monitoring of blood 
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glucose, healthy eating, and regular physical activity that are gained through diabetes 
self-management education (ADA, 2018; Brunisholz et al., 2014; Chew et al., 2014; 
Dirani, Crowston, & vanWijngaarden, 2014; Do et al., 2015; Rosiek et al., 2016; Yu et 
al., 2015). Although adult African Americans are disproportionately affected by DM and 
diabetic retinopathy, adequate management of the disease—including early detection of 
diabetic retinopathy—may be elusive to this population due to racial and ethnic 
disparities in health care access in the United States (Hu, Shi, Liang, Haile, & Lee, 2016; 
Laiteerapong et al., 2015). There is a need to understand the association between some of 
the factors affecting health care utilization and diabetic retinopathy in adult African 
Americans with DM.  
This research examined the association between health utilization factors of 
gender (predisposing), concordant comorbidities of hypertension and hyperlipidemia 
(need), health access (enabling), and diabetic retinopathy among sampled adult African 
Americans with DM in the United States. I analyzed data from a nationally representative 
dataset, the 2011-2016 National Health and Nutrition Examination Survey (NHANES) 
dataset (National Center for Health Statistics (NCHS), 2017a). Participants were adult 
African Americans with self-reported diabetes. I utilized the Andersen model of health 
services use, which purports that predisposing, enabling, and need factors influence 
individuals’ health care utilization (Andersen, 1968; Andersen & Newman, 1973). I used 
the model in examining the relationships between diabetic retinopathy in African 
Americans and the demographic predisposing factor of gender; need factors of DM, 
hypertension, and hyperlipidemia, and enabling factors that facilitate health care access 
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such as health insurance, availability of preventive, diagnostic services including eye 
screening services, and treatment services for DM and its comorbidities; availability of 
doctors and diabetes specialists; and geographic accessibility (Andersen, 1968; Andersen 
& Newman, 1973). There is a paucity of research on the associations between (a) a 
predisposing demographic factor of gender, (b) need factors such as DM comorbidities of 
hypertension and hyperlipidemia, and (c) enabling factors of health care access, which 
are all determinants of health care utilization and diabetic retinopathy in adult African 
Americans with DM in the United States. I conducted this research to identify health 
utilization factors associated with diabetic retinopathy that disproportionately affects 
adult African Americans with its sight-related functional and socioeconomic burdens. 
Through this research, a gap will be filled in literature with the understanding of the 
factors mentioned above responsible for diabetic retinopathy disparities in African-
American populations. 
This section includes (in the following order) the problem statement, purpose of 
the study, research questions and answers, theoretical foundation of the study, nature of 
the study, literature search strategies, literature review related to key variables and 
research questions, definitions, assumptions, scope and delimitations, significance, 
summary, and conclusions. 
Problem Statement 
In the United States, African American populations are disproportionately 
affected by diabetic retinopathy, which is related to the duration of diabetes, uncontrolled 
hyperglycemia, and hypertension (Beckman & Creager, 2016; Lin et al., 2015; Magnan et 
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al., 2015; Mozaffarian et al., 2016; Pantalone et al., 2015; Rosiek et al., 2016; Zhuo et al., 
2014). Diabetic retinopathy can be prevented through strict control of blood sugar, 
hypertension, and hyperlipidemia, early detection of diabetic retinopathy through regular 
eye-screening of patients with DM, and prompt management of diabetic retinopathy, 
which depends on health care utilization that may be elusive to adult African Americans 
with DM (Atchison & Barkmeier, 2016; Chen et al., 2014; Chew et al., 2014; Do et al., 
2015; Hu et al., 206; Laiteerapong et al., 2015; Lee et al., 2015; Lima et al., 2016; 
Mendanha et al., 2016; Romero-Aroca et al., 2016; Ting et al., 2016; Wat et al., 2016). 
There is a dearth of research on the association between (a) predisposing demographic 
factor of gender; (b) need factors such as DM comorbidities of hypertension and 
hyperlipidemia; and (c) enabling factors of health care access that are determinants of 
health care utilization and diabetic retinopathy in adult African Americans in the United 
States. This research was informed by the Andersen model of health services use. This 
study helps fill the gap in the literature regarding the factors responsible for diabetic 
retinopathy disparities in African American populations.  
Purpose of the Study 
This was a quantitative research study, aimed at investigating the relationships 
between health utilization factors such as DM comorbidities, gender, health care access, 
and diabetic retinopathy among African Americans. I examined the relationship between 
the independent variables of (a) gender, (b) comorbidities of DM (e.g., hypertension 
hyperlipidemia), and (c) facilitators of health care access (e.g., current health insurance, 
primary care provider, diabetes specialists, and eye screening service) and the dependent 
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variable of diabetic retinopathy. Covariates included education level, gender, and marital 
status (predisposing factors), annual household income (health care access), and urinary 
albumin-creatinine ratio (UACR) and HBA1C (need factors). For this study, I analyzed 
data from a nationally representative dataset, the 2011-2016 NHANES dataset. 
Research Questions and Hypotheses 
Research Question 1: Is there an association between gender and diabetes 
retinopathy among adult African Americans in the United States? 
Hо1: There is no association between gender and diabetes retinopathy among 
adult African Americans in the United States 
H₁1: There is an association between gender and diabetes retinopathy among adult 
African Americans in the United States. 
Research Question 2: Is there an association between DM-related comorbidities of 
hypertension, hyperlipidemia, and diabetic retinopathy among adult African American 
populations in the United States? 
Hо2: There is no association between DM-related comorbidities of hypertension, 
hyperlipidemia, and diabetic retinopathy among adult African American populations in 
the United States. 
H₁2: There is an association between DM-related comorbidities of hypertension, 
hyperlipidemia, and diabetic retinopathy among adult African American populations in 
the United States. 
Research Question 3: Is there an association between health care access and 
diabetic retinopathy among adult African Americans in the United States?   
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Hо3: There is no association between health care access and diabetic retinopathy 
among adult African Americans with DM in the United States. 
H₁3: There is an association between health care access and diabetic retinopathy 
among adult African Americans with DM in the United States. 
Framework for the Study 
As a framework for this study, I used the Andersen model of health services use, 
which purports that predisposing, enabling, and need factors influence individuals’ health 
care utilization (Andersen, 1968; Andersen & Newman, 1973). Predisposing factors are 
sociodemographic characteristics, such as age, gender, race/ethnicity, education, 
employment, and marital status; need factors are motivators of health care use, including 
perceived need by individuals and assessed health status, which includes chronic health; 
enabling factors are those factors that facilitate the use of health care services by 
individuals, such as household income, availability of health care insurance, having a 
regular doctor, availability of needed services, and distance to the health care facility 
(Andersen, 1968; Andersen & Newman, 1973). The model is adaptable, and researchers 
have widely used it to examine factors that lead to health services utilization in various 
settings (Andrej et al., 2016; Brzoska et al., 2017; Hirshfield et al., 2018; Li et al., 2016; 
Luo et al., 2018; McClure et al., 2016; Petrovic & Blank, 2015; Tesfaye et al., 2018) The 
model is suitable in examining the relationship between the (a) demographic predisposing 
factor of gender; (b) enabling factors that facilitate health care access, including health 
insurance, availability of preventive and diagnostic services (e.g., eye screening services), 
treatment services for DM and comorbidity of hypertension and hyperlipidemia, 
10 
 
availability of doctors and diabetes specialists, and geographic accessibility; and (c) need 
factors that include hypertension, hyperlipidemia, and diabetic retinopathy, which is an 
indirect measure of health care utilization in adult African Americans (Andersen, 1968; 
Andersen & Newman, 1973).   
Nature of the Study 
This research was a quantitative, nonexperimental, correlational cross-sectional 
study aimed at exploring the relationships between independent variables (i.e., gender, 
comorbidities of DM and hypertension, and health care access) and the dependent 
variable of diabetic retinopathy among a large sample of adult African Americans in the 
United States from 2015 to 2016. Covariates included education level, age group, marital 
status, albuminuria, HBA1C level, and income level. Data analyzed in this study were 
from a nationally representative dataset, the 2015-2016 NHANES dataset (CDC, 2017a).  
Literature Search Strategies 
In conducting the literature review, I used academic search engines and databases, 
including the Walden University Library search catalog, PubMed, Medline, ProQuest, 
Google Scholar, SAGE Journals, ScienceDirect, Thoreau Multi-Database Search, 
CINAHL & MEDLINE combined Search, and Cochrane. Criteria for inclusion in the 
literature review were primary peer-reviewed research articles on diabetic retinopathy, 
risk factors for developing diabetic retinopathy generally and among African Americans, 
diabetes comorbidities and diabetic retinopathy, eye care service utilization among adult 
African Americans with diabetes, and access to health care in African Americans. 
Keyword search emphasized locating articles on Andersen model of health services use, 
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and studies informed by the Andersen model of health services use. To find literature on 
adult African Americans with diabetes and retinopathy search terms included 
comorbidities and retinopathy, perceptions of adult African Americans on diseases, 
sociodemographic influence on diabetic retinopathy, access to health care in African-
Americans, access to health care in African Americans with DM, access to health care in 
African Americans with DM and retinopathy, eye screening service use among adult 
diabetics, and screening service utilization among adult African Americans with diabetes. 
The selected articles were written in English, peer reviewed, and not older than 2014 
except seminal articles on the Andersen model of health services use, which is the 
theoretical framework for this research, and articles that filled gaps in the literature. In 
addition to the academic search engines, grey literature sources such as non-peer-
reviewed government and nonprofit publications including the CDC and the Agency for 
Healthcare Research and Quality websites were searched for data; the U.S. Department of 
Agriculture and U.S. Department of Health and Human Services websites were searched 
for dietary practice guidelines; the U.S. Department of Health & Human Services/Office 
for Human Research Protections website was also searched for information on basic 
health and human services policy on protection of human research participants; and the 
ADA and American Academy of Ophthalmologists websites were searched for practice 
guidelines and definitions. 
Literature Review Related to Key Variables and Concepts 
From the literature search, I selected 56 articles that met the inclusion criteria. 
Among these articles were critical reviews of the literature related to DM comorbidities 
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and diabetic retinopathy, sociodemographic risk factors for diabetic retinopathy, and 
factors that determine health care access among African Americans. The study design for 
many of the selected articles was cross-sectional; other study designs used included 
longitudinal, prospective, retrospective, randomized clinical trial, case study, quasi-
experimental, mixed methods, pre-post, surveys, and systematic reviews. The literature 
review is presented according to the framework for this study and key variables of 
diabetic retinopathy, gender, DM comorbidities associated with diabetic retinopathy, 
health care access, and research questions. 
Constructs of the Andersen model of health services use suggest that 
predisposing, enabling, and need factors influence individuals’ health care utilization 
(Andersen, 1968; Andersen & Newman, 1973). Predisposing factors are 
sociodemographic such as age, gender, race/ethnicity, education, employment, household 
income, and marital status; need factors are motivators of health care use that include 
perceived need by individuals, assessed health status that includes chronic health such as 
DM, hypertension, hyperlipidemia, albuminuria, and HBAIC; and enabling factors that 
facilitate the use of health care services by individuals such as availability of health care 
insurance or ability for out-of-pocket-payment, having a regular doctor, availability of 
needed services, and distance to the health care facility (Andersen, 1968; Andersen & 
Newman, 1973). The model was developed by Andersen in 1968 but has evolved 
(Andersen, 1968; Andersen & Newman, 1973). It has been widely utilized in examining 
the factors that lead to health services utilization in various settings (Andrej, Rok, & 
Prevolnik, 2016; Brzoska, Erdsiek, & Waury, 2017; Hirshfield et al., 2018; Li et al., 
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2016; Luo et al., 2018; McClure et al., 2016; Petrovic & Blank, 2015; Tesfaye et al., 
2018). For example, Hirshfield et al. (2018) used this model as a framework for a cross-
sectional study to examine risk factors for developing hypertension among a sample of 
7,454 men with male sexual partners in the United States. According to Hirshfield et al., 
even though about a third of U.S. men are living with hypertension, the diagnosis and 
management of which depend on health care utilization, there is a dearth of studies on 
hypertension among men who have sex with men. The following factors were identified: 
predisposing factors of race, age, education, relationship status; need factors such as 
perception of being overweight, living with DM, heart disease, stroke, anxiety or 
depression; and enabling factors of having a regular doctor, current income, current 
health insurance, residence in South Atlantic or South Central; self-report of hypertension 
was used as a proxy measure of health care utilization (Hirshfield et al., 2018).  
In this research, the Andersen model of health services use is suitable for 
examining the associations between the main independent variables and covariates of 
sociodemographic predisposing factors, need factors, enabling factors, and the dependent 
variable of diabetic retinopathy that is an indirect measure of health care utilization 





















Figure 1. Conceptual framework for associations between DM comorbidities, gender, 
and diabetic retinopathy among adult African Americans with DM. 
 
Diabetic Retinopathy 
Diabetic retinopathy is a common DM complication (Lin et al., 2015; Magnan et 
al., 2015; Pantalone et al., 2015; Rosiek et al., 2016). Diabetic retinopathy occurs when 
chronic high levels of blood glucose cause damage to blood vessels in the retina, which 
can lead to (a) swelling and leaking, or (b) closure of the retinal blood vessels that can 
prevent passage of blood through the blocked vessels, and (c) new blood vessel formation 
in the retina (American Academy of Ophthalmology, 2018b). Diabetic retinopathy is 
separated into two main stages that include the early stage, nonproliferative diabetic 
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retinopathy, which affects many individuals with diabetes and may be symptomless, and 
proliferative diabetic retinopathy in the late and more advanced stage, which may be 
vision-threatening (American Academy of Ophthalmology, 2018b). 
In the United States, diabetic retinopathy is the most common microvascular 
complication of diabetes and is the primary cause of new cases of blindness among adults 
living with diabetes between ages of 20 and 74 years (Jani et al., 2017). Results of a 
cross-sectional study (analysis of data from NHANES 2011 - 2014 cycles) conducted by 
Shah (2016) suggested that the prevalence of diabetic retinopathy among U.S. adults, 40 
years old and over, was 14.7% (95% confidence interval [CI], 11.7–17.8%); prevalence 
among males was 16.1% (95% CI, 13.0–19.1%), and among females was 13.4% (95% 
CI, 9.2–17.5%). In a cross-sectional study from the analysis of NHANES 2005-2008 
data, Zhang et al. (2010) demonstrated diabetic retinopathy prevalence of 28.5% (95% 
CI, 24.9–32.5%) and vision-threatening diabetic retinopathy prevalence of 4.4% (95% 
CI, 3.5–5.7%), which was higher among adult African Americans compared to Whites 
(38.8% versus 26.4%, p = .01), and slightly higher among males than females (31.6% 
versus 25.7%, p = .04); independent risk factors were male gender, longer duration of 
diabetes, insulin use, higher HBA1C level, and higher systolic blood pressure. Duration 
of diabetes, uncontrolled hyperglycemia, and hypertension are common important risk 
factors for the progression of diabetic retinopathy to the vision-threatening type or loss of 
vision (Atchison & Barkmeier, 2016; Chen et al., 2014; Chew et al., 2014; Do et al., 
2015; Lee et al., 2015; Lima et al., 2016; Mendanha et al., 2016; Romero-Aroca et al., 
2016; Ting et al.,  2016; Wat et al., 2016). Longer duration of diabetes, uncontrolled 
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hyperglycemia, hypertension, and dyslipidemia are associated with diabetic retinopathy 
in adult African Americans (Papavasileiou et al., 2017; Penman et al., 2016). 
Diabetic retinopathy is a leading cause of preventable eye damage, which includes 
blindness; each year 12,000–24,000 new cases of blindness are caused by diabetic 
retinopathy (Skaggs et al., 2017). Diabetic macular edema is a significant cause of sight 
loss in 1038 individuals living with DM (Varma et al., 2014). Results of a cross-sectional 
study (data from NHANES 2005-2006 and 2007-2008 cycles were analyzed) by Varma 
et al. (2014) suggested that African Americans with diabetes have a higher likelihood of 
developing diabetic macular edema. Longer duration of diabetes and elevated levels of 
HBAIC were associated with its prevalence. As a significant cause of socioeconomic 
burden in the United States, results of a cross-sectional study by Willis et al. (2017) on 
1004 adults living with diabetes in the United States showed a significant relationship 
between sight-related functional burden and types of diabetic retinopathy with high 
severity.  
There is a need for preventive measures against diabetic retinopathy of high 
severity to minimize sight-related functional burden among adults living with diabetes in 
the United States because there is a higher likeliness of not being involved in any gainful 
employment due to decreased vision (Sherrod et al., 2014; Willis et al., 2017). 
Understanding the factors that determine the utilization of treatment and preventive DM 
services by adult African Americans with diabetes will be useful for developing 
appropriate services. As such, research on the relationships between health care 




In the United States, there is no significant gender-related difference in the 
prevalence of diagnosed DM among adults (CDC, 2017). Systematic reviews by Ozawa 
et al. (2015) and Wat et al. (2016) did not demonstrate a strong association between 
gender and retinopathy. However, the results of Zhang et al.’s (2010) cross-sectional 
study in the United States showed that male gender is an independent risk factor for 
diabetic retinopathy. Similar results were obtained from a cross-sectional study among 
adult Saudi diabetic patients by Abdulghani et al. (2018), which showed an association 
between male gender and diabetic retinopathy. Although there was no statistically 
significant difference in diabetic retinopathy incidence in the Los Angeles Latino eye 
study, males had a 50% higher risk of having any diabetic retinopathy (OR = 1.50; p = 
.006) compared with women as demonstrated by their stepwise multivariate model 
(Varma et al., 2007). Similar results were demonstrated by the United Kingdom 
prospective diabetes 50 study; there was no difference in diabetic retinopathy rates 
between male and female sexes (p = 0.67), but there was a lower risk ratio of diabetic 
retinopathy progression in women as shown by a multivariate model (Strutton et al., 
2001).  
Review of literature on the relationship between gender and diabetic retinopathy 
showed that the association between gender and development of diabetic retinopathy has 
not been established. Even though the results of Zhang et al.’s (2010) study on a 
representative sample of the United States population suggested that male gender is an 
independent risk factor for diabetic retinopathy, the prevalence was higher among Whites 
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59.7 %; 95% Cl, 49.5%–69.1%) compared to African Americans (24.0%; 95% Cl, 
18.2%–30.8%; p = .008). The cross-sectional design of this study will affect the 
generalizability of the result beyond the study population. The study by Penman et al. 
(2015) was on adult African Americans with diabetes, but only the results for female 
participants was reported and was statistically insignificant (60.3%; p = .27); moreover, 
small sample size and purposive sampling design utilized will affect the generalizability 
of the results beyond the study population. There was a need to carry out a study on the 
association between gender and diabetes retinopathy among adult African American 
population on a large sample that is representative of this population. 
Comorbidities 
DM is associated with concordant comorbidities such as hypertension and 
hyperlipidemia that are major risk factors in the development of macro and microvascular 
diseases (Abdulghani, et al., 2018; Atchison & Barkmeier, 2016; Beckman & Creager, 
2016; Cheng et al., 2014; Klimek et al., 2015; Lin et al., 2015; Magnan et al., 2015; 
Mozaffarian et al., 2016; Pantalone et al., 2015; Raum et al., 2015; Romero-Aroca et al., 
2016; Rosiek et al., 2016; Solomon et al., 2017; Song et al., 2016; Wat et al., 2016; 
Walraven et al., 2015; Zhuo et al., 2014). Cardio-metabolite risk factors for diabetic 
retinopathy include hypertension, hypertriglyceridemia, hypocholesterolemia (HDL), and 
abdominal obesity (Cheng et al., 2014). According to the results of a study by Cheng et 
al. (2014) in China, diabetic retinopathy prevalence when associated with one, two, three, 
and four of the cardio-metabolites was 16.0%, 17.6%, 21.3%, and 25.1%, (p = .001) 
respectively. However, results of a prospective cohort study on 759 adult diabetic patients 
19 
 
(25-75 years) without diabetic retinopathy in Korea (followed up for 11 to 12 years), 
suggested that glycemic control, age, and albuminuria were significant risk factors for the 
development of diabetic retinopathy (Yun et al., 2016).  
DM concordant comorbidities of hypertension and hyperlipidemia are major 
intermediate factors underlying cardiovascular disease such as diabetic retinopathy 
disparities of African American populations (Beckman & Creager, 2016; Lin et al., 2015; 
Magnan et al., 2015; Mozaffarian et al., 2016; Pantalone et al., 2015; Rosiek et al., 2016; 
Zhuo et al., 2014). Results of a cross-sectional study (analysis of NHANES data from 
1999 to 2012) by Song et al. (2016), showed an increase in the prevalence of coexisting 
diabetes, hypertension and hypercholesterolemia among United States adults from 3% in 
1999–2000 to 6.3% in 2011–2012 (p < .001). According to Song et al. concordant 
comorbidities of DM, hypertension, and hyperlipidemia in 2012 was higher among 
African Americans (10.2%, p < .001), compared to Mexican Americans (6.1 %, p = 
.020), other Hispanics (6.6%, p = .220), Whites (5.6%, p < .001), and other racial and 
ethnic groups (7.3%, p = .450). A study was carried out by Penman et al. (2015) to 
examine individual and demographic risk factors for proliferative diabetic retinopathy in 
adult African Americans with T2DM. African Americans with Type 2 diabetes (n = 358) 
were recruited from four sites in Mississippi and Massachusetts (Penman et al.). The 
results demonstrated that longer duration of diabetes (OR, 1.62, p < .001), systolic 
hypertension (OR 1.65,  p < .001), and insulin treatment (OR 6.65, p < .001) were strong 
risk factors for the development of proliferative diabetic retinopathy (Penman et al.). 
Although HBA1C was statistically significant in the univariate analysis (OR 1.3, p = 
20 
 
.002), it was not significant in multivariate analysis (OR 1.04, p = 0.68) (Penman et al). 
Total cholesterol (p = 0.42), triglyceride (p = 0.49); LDL cholesterol (p = 0.39); and HDL 
cholesterol (p = 0.52), were not statistically significant (Penman et al.). 
Hypertension and hyperlipidemia are modifiable diabetes concordant 
comorbidities. Several studies have demonstrated that hypertension and hyperlipidemia 
have positive associations with the development of diabetic retinopathy (Abdulghani, et 
al., 2018; Beckman & Creager, 2016; Cheng et al., 2014; Do et al., 2015; Klimek, 
Kautzky-Willer, Chmiel, Schiller-Frühwirth, & Thurner, 2015; Lin et al., 2015; Magnan 
et al., 2015; Mozaffarian et al., 2016; Pantalone et al., 2015; Romero-Aroca et al., 2016; 
Rosiek et al., 2016; Solomon et al., 2017; Song et al., 2016; Wat et al., 2016; Zhuo et al., 
2014). A meta-analysis by Wang et al. (2015) found a decreased risk of retinopathy of 
about 7 %, decreased risk of progression of diabetic retinopathy of about 5%, and an 
increased probability of diabetic retinopathy regression in diabetics on renin-angiotensin 
system inhibitor. There was a  statistically significant decreased risk of diabetic 
retinopathy progression (0.84, p =.002), and an increased probability of diabetic 
retinopathy regression (1.50, p=.003) in diabetics on treatment with angiotensin-
converting enzyme inhibitors;  however, there was only an association between the use of 
angiotensin receptor blockers and decreased diabetic retinopathy progression (1.32, 
p=.008) (Wang et al.). However, the result of a Cochrane review by Do et al. (2015) 
showed hypertension treatment can prevent diabetic retinopathy but does not slow its 
progression. Results of a Danish study showed that use of statins before diagnosis of DM 
was associated with diabetic retinopathy development; its use was also linked to 
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improvement in visual acuity in those with diagnosed diabetic retinopathy (Nielsen & 
Nordestgaard, 2014). 
Researchers have identified comorbidities associated with diabetic retinopathy 
and the advanced types of proliferative retinopathy and macular edema. Most of the 
studies were on mixed populations with minimal representation of African Americans, 
purposive sampling and cross-sectional study designs were mostly used, which will affect 
the generalizability of the study results beyond the study populations. There was a need 
to identify comorbidities associated with diabetic retinopathy on a large representative 
sample of adult African Americans. 
Health Care Access 
Health care access is the ability to gain entry into or utilize personal health care 
service for achieving optimum outcomes in health (HealthyPeople.gov., 2018). Three 
steps involved in achieving health care access include (a) getting into the health care 
system that is commonly through medical insurance coverage, (b) geographic 
accessibility of required health care services, and (c) identifying a trustworthy health care 
provider that can be easily communicated with (HealthyPeople.gov., 2018). Prevention of 
diabetic retinopathy and its progression to its vision-threatening type depend on health 
care access (Atchison & Barkmeier, 2016; Chen et al., 2014; Chew et al., 2014; 2016; Do 
et al., 2015; Lee et al., 2015; Lima et al., 2016; Mendanha et al., Romero-Aroca et al., 
2016; Ting et al; Wat et al., 2016).   
Obtaining recommended diabetes preventive services is dependent on the status of 
medical insurance (Bailey et al., 2016).  Bailey et al. (2016) carried out a retrospective 
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cohort research to determine any relationship between disparities in diabetes prevention 
services obtained and status of medical insurance during health care facility visit. 
Medicaid and electronic health record data of study participants from 38 community 
health centers in Oregon from 200-2007 were analyzed (Bailey et al.). Study participants 
were categorized as patients that were insured throughout the study period (continuously 
insured), uninsured throughout the study period (continuously uninsured), and those 
without insurance for part of the study period (discontinuously insured). There were 
1,466 patients that were insured continuously; 1,117 uninsured continuously; and 336 
insured discontinuously (Bailey et al.). Results suggested that patients without continuous 
insurance had lower odds of obtaining diabetes prevention services during scheduled 
visits compared to patients with continuous insurance (odds ratio = 0 .73, 95% CI = 
0.66); and among the patients without insurance for part of the study period, probability 
of not obtaining diabetes preventive services due for the scheduled visit was associated 
with not being insured at that particular clinic visit (odds ratio =0.77, 95% CI = 0.64) 
compared to when insured at the particular clinic visit (Bailey et al.). 
Early detection of diabetic retinopathy is of extreme importance in preventing loss 
of vision, and timely medical and surgical treatments have dramatically reduced diabetic 
retinopathy progression (Jani et al., 2017). The effectiveness of diabetic retinopathy 
screening programs depends on how patients adhere to the schedule of follow-up eye 
management as recommended by the diabetic retinopathy screening program (Keenum et 
al., 2016). Although African Americans are among those at highest risk for diabetic 
retinopathy, they had one of the lowest rates of diabetic retinopathy screening and 
23 
 
scheduled follow-up eye care utilization (Keenum et al., 2016; Maclennan et al., 2014; 
Yu et al., 2015). Factors that influence screening include lack of health care access that is 
influenced by health insurance coverage, transportation, and accessibility to an eye 
specialist, late or non-referrals from primary care physicians, inadequate communication 
between primary care physicians and eye specialists, misinformation about diabetic 
retinopathy screening, miscommunication about patients’ addresses, patients’ detachment 
from diabetes care, and lack of diabetes-management education in those living with 
diabetes (Al-Alawi et al., 2016; Chou et al., 2014; Hipwell et al., 2014; Jani et al., 2017; 
Kashim et al., 2018; Lindenmeyer et al., 2015; MacLennan et al., 2014; Piyasena et al., 
2019; Spears et al., 2018; Strutton et al., 2016).  
In a prospective follow-up study, Keenum et al. (2016) examined the rate of 
adherence to recommended follow-up eye care in a diabetic retinopathy screening 
program administered in a health care facility that provides access to care irrespective of 
the patients’ affordability. Study participants were individuals with Type 1 diabetes or 
T2DM receiving care in an internal medicine clinic of a health system with retinopathy 
screening program in Alabama that is publicly funded, which serves a predominantly 
uninsured African American population (Keenum et al.). Results suggested that after the 
diabetic retinopathy screening, only a third of study participants adhered to scheduled 
intervals for follow-up eye care despite minimizing accessibility and costs as barriers to 
eye care (Keenum et al.). Keenum et al. suggested incorporating eye education strategies 
to promote adherence to recommended eye care that can prevent loss of vision from 
diabetic retinopathy.   
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Telemedicine is an emerging strategy for improving evaluation for diabetic 
retinopathy through retinal imaging in the primary care setting with remote interpretation 
by an expert (Jani et al., 2017; Mansberger et al., 2015). In the United States, diabetic 
retinopathy was identified in 1 out of 5 individuals living with diabetes through a diabetic 
retinopathy telemedicine screening offered in urban clinical or pharmacy environments 
largely that were mostly utilized by racial and ethnic minorities (Owsley et al., 2015). A 
pre- and post-implementation evaluation by Jani et al. (2017) at five primary care clinics 
providing health care services to underserved populations in North Carolina showed that 
rate of diabetic retinopathy evaluation is increased by retinal telemedicine screening for 
diabetic retinopathy in patients in underserved populations; access to care for minorities 
and patients with diabetic retinopathy requiring treatment in the primary care setting 
might also be increased. With early identification of patients at risk of loss of vision, 
retinal telemedicine programs can lead to decreased health care costs and reduce the 
socioeconomic burden of vision-threatening visual loss on the society (Jani et al.). 
Although health care access plays a vital role in diabetic retinopathy screening, 
the quality of services offered may not be equal in all health care institutions due to 
disparities in preventive care that are usually provided in primary care encounters. Even 
though primary care encounters usually provide opportunities for preventive health care 
such as diabetes self-management education (DSME), there are considerable race and 
ethnic disparities in preventive care that are usually provided in primary care encounters; 
access to quality health care as offered in primary care centers is limited to many African 
Americans with diabetes, they rely on government-subsidized and less-resourced 
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community health centers located in their residential areas for medical care (Agency for 
Healthcare Research and Quality, 2017; Fiscella, K. & Sanders, 2016). Racial and ethnic 
disparities exist in quality of care provided for control of chronic noncommunicable 
diseases such as hypertension, hyperlipidemia, and diabetes that are risk factors for 
diabetic retinopathy, with African Americans and other minority patients having 
suboptimal control for blood sugar, blood cholesterol, and blood pressure with resultant 
complications that include diabetic retinopathy (Agency for Healthcare Research and 
Quality, 2017; Laiteerapong et al., 2015; Yoon et al., 2015). Abramson, Hashemi, and 
Sánchez-Jankowski (2015) carried out a cross-sectional study that employed a multi-level 
approach to examine perceptions of United States racial health care discrimination and 
micro and macro-level factors that influence behaviors, health experiences, and outcomes 
among and between racial groups. Data on 43,020 adults between 18 and 85 years from 
California's major racial and ethnic groups obtained from the California Health Interview 
Survey 2005 were analyzed (Abramson et al.). Results showed that racial minorities, 
especially African-Americans reported more racial health care discrimination; increased 
perceptions of discrimination were associated with poor communication with health care 
provider across all racial and ethnic groups; and perceptions of discrimination were 
associated with an increased level of education in all racial and ethnic groups except 
Whites (Abramson et al.). 
Laiteerapong et al. (2015) carried out a cross-sectional study to determine 
disparities in diabetes care. The study sample was a nationally representative sample of 
Hispanics, African Americans, and Whites, aged 20 years or over, with self-reported 
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diabetes in the NHANES, 2007–2010. There were individualized glycemic goals that 
were assigned based on duration, age, duration, comorbidity, and complications; and, 
low-density lipoprotein cholesterol goals assigned based on the history of cardiovascular 
disease (Laiteerapong et al.). The results showed that more Whites  achieved HBA1C < 
8% goal than African Americans (81% versus 74%, p < .001); fewer African Americans 
were recommended individualized LDL goals compared to Whites (10% versus 33%, p < 
.003 ; more Whites (51%) achieved individualized LDL control; and adequate blood 
pressure control goal of less than 140/90 mmHg was reached by fewer African 
Americans compared to Whites (53% versus 69%, p < .001).  
A cross-sectional study was carried out by Assari et al. (2017) on 163 African 
Americans with T2DM in outpatient clinic of a large Midwestern urban health care 
system to examine dissimilarities in levels of racial health care discrimination perceptions 
and the relationship between the perceived discrimination and blood sugar control. 
Results demonstrated that racial health care discrimination is reported more by African 
American men with T2DM than women with T2DM; perceived discrimination is 
associated higher levels of HBA1C in African American men (Assari et al.). Assari et al. 
suggested that consideration should be given to gender by clinicians and academics when 
the effects of racial health care discrimination on health outcomes are being examined.  
Several factors may influence racial disparities in diabetes management services. 
Hu et al. (2016) carried out a cross-sectional study to determine the factors that may 
influence racial disparities in primary care access and quality in those with diabetes by a 
secondary data analysis on 2,617 adults with self-reported T2D derived from the 
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household part of the Medical Expenditure Panel Survey of 2012. The results showed that 
although there were initial racial and ethnic disparities in the access to primary care and 
quality, socioeconomic status is a stronger determinant of access to primary care and 
quality and outcomes in those with T2DM than race and ethnicity (Hu et al.). According 
to the authors, the policy implication of the result is that policymakers should ensure 
equitable health care access and quality to all by focusing on the health care needs of the 
underprivileged and underserved populations such as those with lower socioeconomic 
status (Hu et al.). In Canada, Bird, Lemstra, Rogers, and Moraros (2015) from a cross-
sectional study found that household income has a strong and independent association 
with the prevalence of T2DM and some concordant comorbidities and physical inactivity. 
Relationship between disparities in diabetes prevention services obtained and status of 
medical insurance during health care facility visit was suggested by results of a 
retrospective cohort research by Bailey et al. (2016); however, the internal and external 
validity of the results are compromised by the purposive sampling method used and a 
predominantly Hispanic population.  
According to results of the study by Ascari et al, (2017), discrimination is 
reported more by African American men with T2DM than women with T2DM and 
perceived discrimination is associated higher levels of HBA1C in African American men; 
however internal and external validity of the results are affected by the cross-sectional 
study design and purposive sampling method. Results of studies by Bird et al. (2015) and 
Hu et al. (2016) highlighted the intrapersonal and community-level factors that influence 
health care access and quality in T2DM patients. Results of the study by Hu et al. (2016) 
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showed that socioeconomic status is a stronger determinant of access to primary care and 
quality and outcomes in those with T2DM than race and ethnicity; however, self-report of 
DM and primary care experience without measuring health outcomes, use of secondary 
data source, nonprobability sampling, and cross-sectional study design, and a 
predominantly White study population will affect both internal and external validity of 
study findings. Also results of a cross-sectional study by Bird et al. showed that 
household income has a strong and independent association with the prevalence of T2DM 
and some concordant comorbidities and physical inactivity; absence of African 
Americans in the study population affects the generalizability of the results beyond the 
study population. Research findings from studies carried out by Chow et al. (2016) and 
Young et al. (2017) highlighted the importance and quality of health care access; 
although the study by Young et al. was supposed to be a randomized control trial, not all 
patients stuck to their assigned groups; also, the purposive sampling method utilized by 
Chow et al. and lack of information about the racial or ethnic composition of the study 
population will affect the generalization of the study results.  
There are low eye care service utilization rates among adult African Americans 
with DM, which result in lower screening rates among this population (Maclennan et al., 
2014; Yu et al., 2015). Research is scarce specifically on the associations between DM 
comorbidities of hypertension and hyperlipidemia, gender, health care access diabetic 
retinopathy among adult African Americans with diabetes in the United States. There was 
a need to conduct research specifically on these factors that affect health care utilization 
among adult African Americans with DM and diabetic retinopathy in the United States. 
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Studies Related to the Research Questions 
In this study, I analyzed the associations between gender, DM related comorbidity 
of hypertension and hyperglycemia, and diabetic retinopathy among adult African 
Americans in the United States. Studies reviewed on the association between gender and 
diabetic retinopathy in adult African Americans are indeterminate, which warranted a 
study to examine this relationship in this population (Research Question 1). Although the 
literature review showed that concordant comorbidities of DM, hypertension, and 
hyperlipidemia are risk factors for the development of diabetic retinopathy and its 
progression to proliferative diabetic retinopathy, the study populations were 
predominantly not African Americans (Atchison & Barkmeier, 2016; Chen et al., 2014; 
Chew et al., 2014; Do et al., 2015; Lee et al., 2015; Lima et al 2016; Mendanha et al., 
2016; Romero-Aroca et al., 2016; Ting et al., 2016; Wat et al., 2016). The cross-sectional 
design used for the studies on African Americans and purposive sampling can affect the 
generalizability of the research findings (Papavasileiou et al., 2017; Penman et al., 2016). 
There is a need for research on the association between DM comorbidities and diabetic 
retinopathy among adult African Americans in the United States (research question 2). 
Literatures reviewed showed that the achievement of  metabolic control of 
hyperglycemia, hypertension, and hyperlipidemia, early detection through regular eye-
screening of patients with DM, and prompt management of diabetic retinopathy could 
prevent the development of early diabetic retinopathy and the progression to the late 
stages; these diabetes preventive services are dependent on health care utilization that 
depend on health care access (Atchison & Barkmeier, 2016; Chen et al., 2014; Chew et 
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al., 2014; Do et al., 2015; Lee et al., 2015; Lima et al., 2016; Mendanha et al., 2016; 
Romero-Aroca et al., 2016; Ting et al., 2016; Wat et al., 2016). Three studies showed that 
although African Americans are among those are disproportionately affected by diabetic 
retinopathy, they had one of the lowest rates of diabetic retinopathy screening and 
scheduled follow-up eye care utilization (Keenum et al., 2016; Maclennan et al., 2014; 
Yu et al., 2015). There was a need to research the factors that affect health care access 
among adult African Americans with DM (research question 3). 
Definitions 
Comorbidity: Is when there is concurrent existence of a disease and one or more 
other diseases in an individual (Pantalone et al., 2015).  
DM comorbidity: Can be concordant (similar) or discordant (not similar) 
according to the management of DM (Magnan et al., 2015).   
DM concordant comorbidities: DM, hypertension, hyperlipidemia, large and 
small arterial diseases (Lin et al., 2015; Magnan et al., 2015; Mozaffarian et al., 2016; 
Pantalone et al., 2015; Rosiek et al., 2016).  
Diabetic Retinopathy: An extreme small blood vessel (arteriole) complication of 
the eyes in both Type 1 and Type 2 diabetes; it is strongly related to both the duration of 
poor blood sugar control in diabetes, and how controlled the blood sugar level is (ADA, 
2018). 
Health care access: The ability to gain entry into or utilize the health care service 
(HealthyPeople.gov. (2018). 
Albuminuria: Presence of albumin (type of protein) in the urine (ADA, 2018). 
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African American: Individuals with any ancestry of African tribes, especially 
those of Black African ancestors (Merriam-Webster, Incorporated, 2018). 
Eye screening: Useful for those with DM in identification eye conditions such as 
diabetic retinopathy that may result in vision loss (American Academy of 
Ophthalmology, 2018a). An appropriate referral can then be made to an eye specialist for 
further management (American Academy of Ophthalmology, 2018a). 
Blood glucose: Principal sugar found in the body and the body’s primary source 
of energy (ADA, 2018). 
Diabetes mellitus (DM): A metabolic disorder characterized by chronic 
hyperglycemia (continuing elevated levels of blood sugar) resulting from defects in 
insulin action, insulin secretion, or both (WHO, 2018).  
Type 1 Diabetes mellitus (T1DM) Medical problem with the body when blood 
glucose level rises higher than normal because insulin is not being produced enough 
(ADA, 2018). 
Type 2 Diabetes mellitus (T2DM): Medical problem with the body when blood 
glucose level rises higher than normal because insulin is not being appropriately used, 
insulin not being produced enough (ADA, 2018). 
Hemoglobin A1c (HBA1C): A biochemical measure of average blood sugar within 
three months (WHO, 2018). 
Macroangiopathy: Diseases of large arteries (WHO, 2018). 
Microangiopathy: Diseases of small arteries called arterioles (WHO, 2018). 
Neuropathy: Diseases of nerves (WHO, 2018). 
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Nephropathy: Kidney disease (WHO, 2018).  
Assumptions 
NHANES 2011-2016 datasets were utilized in answering the proposed research 
questions in this study. However, for the datasets’ appropriateness of secondary analysis, 
it is assumed that they are adequate to answer the research questions (Mohajan, 2017; 
Salimi & Ferguson‐Pell, 2017). It is therefore assumed that the datasets have an 
appropriate sample, the random sampling method was utilized, and the quality of the 
measurement instruments has been assured by the reliability and validity of 
measurements that have been established in other settings (Anand et al., 2017; Salimi & 
Ferguson‐Pell, 2017). The study sample of adult African Americans with DM represented 
the population of interest in the study. Andersen model of health services use allowed for 
the exploration of factors that affect health care access that is very significant in the 
prevention of diabetic retinopathy among African Americans. As such it was suitable for 
examining the association between independent variables of predisposing factor of 
gender, the need factor of DM comorbidities, enabling factor of health care access, and 
health care utilization measured as the dependent variable of diabetic retinopathy. 
Scope and Delimitations 
This was a cross-sectional study that explored the association between diabetes 
comorbidities of hypertension and hyperlipidemia, gender, health care access, and 
diabetic retinopathy in adult African Americans by secondary data analysis of 2011-2016 
NHANES datasets. Adult African Americans with DM are disproportionately affected by 
diabetic retinopathy, as such this population was suitable for this study.  However, there 
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are delimitations of the study such as the exclusion of institutionalized individuals, 
Americans resident outside the 50 states and the district of Colombia, and all active-duty 
servicemen and women with their families residing overseas; as such the results of this 
research may not be generalizable to those that did not qualify for inclusion in the survey 
(CDC, 2017a). Also, a cross-sectional study examines relationships between multiple 
variables in a specified population at a particular time-frame, so the results are fixed 
without any indication of the order of events; cause and effect from simple association 
cannot be established (Caruana, Roman, Hernández-Sánchez, & Solli, 2015; Mariani & 
Pego-Fernandes, 2014; Omair, 2015; Setia, 2016).  
Significance 
Implications for positive social change from this study is that knowledge gained 
from the study will be useful in planning and developing effective public health 
interventions targeting specific African American populations, resulting in decreased 
physical, mental, and socioeconomic burdens on this population. In this study, 
determining the factors that influence health care utilization disparities among adult 
African American populations with DM concordant comorbidities will help in identifying 
barriers to the successful implementation of public health interventions in this population.  
According to Walden University (2014), positive social change denotes 
participation in activities that lead to an improvement in the lives of community 
members, nationally or globally (Walden University, 2014). Understanding factors 
responsible for DM comorbidity disparities and diabetic retinopathy in adult African 
American populations can be utilized for their prevention and effective care through 
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development and implementation of culturally appropriate interventions (Sachdeva et al., 
2015). Social change implication of the research is that the results can be useful for the 
successful planning and implementation of public health prevention programs for African 
American populations. The consequence of which should be a decrease in the prevalence 
DR and associated physical, mental, and socioeconomic burdens on populations, 
especially the African American populations that are disproportionately affected (Lang, 
& Marković, 2016; Lin et al., 2015). This should lead to less morbidity, disability, and 
mortality from these diseases, which should lead to increased productivity that will lead 
to an improvement of the socioeconomic status of individuals and the economic status of 
the affected community. 
Andersen model of health services use allowed for the exploration of factors that 
affect health care access that is very significant in the prevention of diabetic retinopathy 
among African Americans. The model’s constructs applied to this study should help in 
understanding the predisposing, need, and enabling factors of health care utilization that 
determine diabetic retinopathy among adult African Americans. In this study, a literature 
review was conducted to identify studies on the influences of gender, DM comorbidities, 
and health care access on diabetic retinopathy. The search yielded several articles, and 
some of the articles related to this present study were selected. Major themes in the 
selected articles are outlined below. 
Summary 
Andersen model of health services utilization allowed for the exploration of 
factors that affect health care access that is very significant in the prevention of diabetic 
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retinopathy among African Americans;  it was suitable for examining the association 
between independent variables of predisposing factor of gender, the need factor of DM 
comorbidities, and enabling factor of health care access and health  utilization that is 
indirectly measured as the dependent variable of diabetic retinopathy (Andersen, 1968; 
Andersen & Newman, 1973). Hypertension and hyperlipidemia have positive 
associations with the development of diabetic retinopathy (Abdulghani, et al., 2018; 
Beckman & Creager, 2016; Cheng et al., 2014; Do et al., 2015; Klimek et al., 2015; Lin, 
Kent et al., 2015; Magnan et al., 2015; Mozaffarian et al., 2016; Pantalone et al., 2015; 
Romero-Aroca et al., 2016; Rosiek et al., 2016; Solomon et al., 2017; Song et al., 2016; 
Wat et al., 2016; Zhuo et al., 2014). Duration of diabetes, uncontrolled hyperglycemia 
and hypertension are common important risk factors for the progression of diabetic 
retinopathy to vision-threatening diabetic retinopathy or loss of vision (Chen et al., 2014; 
Chew et al., 2014; Mendanha et al., 2016; Do et al., 2015; Lee et al., 2015; Lima et al., 
2016; Romero-Aroca et al., 2016; Ting et al., 2016; Wat et al., 2016). Longer duration of 
diabetes, uncontrolled hyperglycemia, hypertension, and dyslipidemia are associated with 
diabetic retinopathy in adult African Americans (Papavasileiou et al., 2017; Penman et 
al., 2016). There are racial, ethnic, and socioeconomic disparities in health care access in 
the United States (Bailey et al., 2016; Hu et al., 2016; Laiteerapong et al., 2015).  
However, there is a dearth of public health research on the associations between a 
predisposing factor of gender, need factors of DM comorbidities (hypertension and 
hyperlipidemia), and enabling factor of health care access and utilization and diabetic 
retinopathy among adult African Americans. This research examined the association 
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between these predisposing, need, enabling factors of health care utilization, and diabetic 
retinopathy among adult African Americans. The results should fill a gap in public health 
knowledge that should contribute to an improvement in population health planning and 
implementation. 
Conclusions 
This research aimed at examining the association between predisposing, need and 
enabling health care factors that influence health care utilization among African 
Americans, which is responsible for diabetic retinopathy disparities in adult African 
American populations. This should help in identifying barriers to the successful 
implementation of public health interventions. A gap will be filled in literature with the 
understanding of the factors responsible for diabetic retinopathy disparities in African 
American populations. 
In the next section, there is discussion about the research study design and data 
collection that include research study design and the rationale for choosing the design; 
methodology with its sub-sections of study population including its size, sampling and 
sampling procedures used in data collection, study instrumentation, and study variables 




Section 2: Research Design and Data Collection 
Introduction 
In this quantitative research, I examined associations between gender, DM 
comorbidities, health care access (independent variables), and diabetes retinopathy 
(dependent variable), among sampled adult African Americans in the United States. 
Covariates were age groups, UACR, HBA1C level, marital status, adult education level, 
and household income. I analyzed data from nationally representative datasets from the 
NHANES 2011-2012, 2013-2014, and 2015-2016 cycles (see NCHS, n.d.) on DEMO 
(demographics), DIQ (diabetes questionnaire), BPQ (blood pressure and cholesterol 
questionnaire), ALB_CR (urine levels), HIQ (health insurance questionnaire), BPX 
(blood pressure measurements), HDL, TCHOL, TRIGLY (blood levels), and GHB 
(HBAIC level). Individual datasets for each cycle were merged to produce a final cycle’s 
dataset, datasets from the three NHANES cycles were appended to produce the final 
dataset, and new a data set specific to the study sample was created. Participants were 
adult African Americans, aged 20 years and above, with a self-reported diagnosis of 
diabetes (NCHS, n.d; Li et al., 2010; Yan et al., 2018). In this section, I discuss the 
research study design and data collection. The discussions are in order of research study 
design and the rationale for choosing the design; methodology with its subsections of 
study population including its size, sampling and sampling procedures utilized used in 
data collection, study instrumentation, and study variables operationalization; threats to 
validity; ethical considerations; and summary. 
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Research Design and Rationale 
The design for this research was a quantitative cross-sectional study. The research 
was approached through a retrospective analysis of nationally representative secondary 
datasets, with both the independent and dependent variables extracted from NHANES 
2011 – 2016 datasets. The independent variables and covariates represent constructs of 
the Andersen model of health services utilization such as predisposing factors (age, 
gender, marital status, education level, and household income); need factors of 
comorbidities (DM, hypertension, hyperlipidemia, HBA1C and UACR); and enabling 
factors of health care access (household income, level, current health insurance, 
availability of regular diabetes doctor, diabetes specialists, and eye-screening service); 
and the dependent variable of diabetic retinopathy that is a proxy measure of health 
services utilization. 
Quantitative research is used in quantifying relationships between the independent 
or predictor variable(s) and the dependent or outcome variable(s) by way of experiments 
or data analysis (Creswell, 2014). Researchers conduct cross-sectional studies to examine 
relationships between multiple variables in a specified population (a representative 
sample from the population) at a particular timeframe (Caruana et al., 2015; Mariani & 
Pego-Fernandes, 2014; Omair, 2015; Setia, 2016). A correlational research design is used 
to examine the existence of a significant linear relationship between the independent 
(predictor) and dependent (outcome) variables; the direction and strength of that 
relationship are also determined (Curtis et al., 2016; Omair, 2015). Correlational research 
designs can be explanatory or predictive (Curtis et al., 2016; Omair, 2015). An 
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explanatory correlational research design involves a cross-sectional data collection 
approach, whereas for a predictive correlational research design, longitudinal data are 
collected (Curtis et al., 2016; Omair, 2015). For this study, I used a correlational cross-
sectional design in examining whether there were significant associations between some 
specific health care utilization factors and diabetic retinopathy among African 
Americans. I chose the correlational cross-sectional study design considering the time 
available for this dissertation, which would not have permitted a longitudinal study 
design because of repeated observations that might be required over a long period 
(Caruana et al., 2015; Curtis et al., 2016; Omair, 2016). Moreover, secondary data used 
for this study were collected within specific time-periods (see NCHS, n.d.).  
Cross-sectional studies are comparatively cheap and quick to carry out; multiple 
measurements can be taken at the same time and is exclusive of variable(s) manipulation. 
Although the results from cross-sectional studies are fixed without any indication of the 
order of events and cause and effect from the simple association cannot be established, 
the associations identified can then be studied rigorously by utilizing randomized control 
trial (RCT) or cohort study (Mariani & Pego-Fernandes, 2014; Setia, 2016). For example, 
identified associations and significant relationships between gender, DM comorbidities of 
hypertension and hyperlipidemia, health care access, and diabetic retinopathy are 
indicators of what can be studied further to ascertain cause and effect through RCT or 





The target population for the NHANES 2011-2012, 2013-2014, and 2015-2016 
cycles was the noninstitutionalized civilian resident population of the United States 
(Asiamah, Mensah, & Oteng-Abayie, 2017; NCHS, 2017a). The researchers used 
oversampling to ascertain accurate representation of underrepresented groups that 
included African Americans, adults Whites 60 years and over, Hispanics, and Asians 
(NCHS, 2017). The target sample for this study were African Americans 20 years or over 
with DM that were study participants in the 2011-2012, 2013-2014, and 2015-2016 
NHANES cycles; a total of 634 (n = 634) study participants. The minimum sample size 
of 308 for this research was calculated from an a priori power analysis utilizing 
G*POWER 3.1.9.2 (Faul, Erdfelder, Buchner, & Lang, 2009). 
Sampling in NHANES 
Sampling is the procedure for selecting sampling units (individuals) from the 
sample frame (Martinez-Mesa et al., 2016). It is important that the sampling plan is 
specified early in the research process since the sample size estimation may be affected 
by the method of sampling (Martinez-Mesa et al., 2016).  
Sampling frame. The sample frame for research is a list of all individuals within 
a target population that can be sampled based on the sampling procedure employed in the 
study (Martinez-Mesa, Gonzalez-Chica, Duquia, Bonamigo, & Bastos, 2016). The 
sampling frame for NHANES is all the U.S. counties (CDC, 2017a).   
Sampling techniques. Quantitative researchers can use either probability 
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sampling methods that employ random participants selection or nonprobability sampling 
methods that utilize convenient and opportunistic sampling techniques for participant 
selection (Martinez-Mesa et al., 2016; Omair, 2014). Probability sampling includes 
simple random sampling, systematic random sampling, cluster sampling, multistage 
sampling, and stratified random sampling (Martinez-Mesa et al., 2016; Omair, 2014). 
Probability sampling techniques are preferred to nonprobability sampling techniques 
because study results can be generalized beyond the study sample to the target population 
(Martinez-Mesa et al., 2016; Omair, 2014). Complex multistage probability sampling 
technique was utilized for 2011-2012, 2013-2014, and 2015-2016 NHANES cycles 
(NCHS, n.d.). Multistage probability technique utilized involves (a) counties sampling 
(primary sampling units); (b) segments sampling; (c) household sampling; and (d) person 
sampling with the use of a computer algorithm that randomly selects some, all, or none of 
the household members (CDC, 2018; Martinez-Mesa et al., 2016; Omair, 2014).  
The combined datasets for 2011-2012, 2013-2014, and 2015-2016 NHANES 
cycles was the sampling frame for this research. NHANES combined interviews 
(household interview, questionnaires, and mobile examination center [MEC] 
questionnaires), physical examination, and laboratory tests (CDC, 2017). After obtaining 
written consent, trained personnel, including medical doctors, administer the 
questionnaires and perform the medical examinations and laboratory tests (CDC, 2017 
n.d.). In this research, I analyzed data on the target sample from the 2011-2012, 2013-
2014, and 2015-2016 NHANES cycles. 
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NHANES data describe the prevalence or trends of disease, nutrition, risk 
behaviors, and environmental exposures in the US population (CDC, 2017). Probability 
sampling allows the survey results to be generalizable to the larger population from 
which the study sample was drawn (CDC, 2017a; NCHS, n.d.). NHANES, which was 
conducted on a periodic basis from 1970 but turned to a continuous survey in 1999, is a 
cross-sectional population-based survey that collects data on demographics, diet and 
nutritional status, risk factors, adolescent health, environmental exposure, reproductive 
health, and chronic diseases on a nationally representative sample of the U.S. population 
(NCHS, 2017). Although 43,090 individuals were selected for NHANES 2011-2012, 
2013-2014, and 2015-2016 cycles from 30 different counties in each cycle, the interview 
was completed by 29,902 individuals, and 28,695 persons went through physical 
examination; response rate for the interviewed sample was 69%; and 66.6% for the 
examined sample (NCHS, n.d.). 
Data Collection and Utilization Procedures for the Current Study 
I analyzed data from the combined 2011-2012, 2013-2014, and 2015-2016 
NHANES datasets, such as DEMO.XPT (demographics), DIQ.XPT (diabetes 
questionnaire), BPQ.XPT (blood pressure and cholesterol questionnaire), ALB_CR.XPT 
(urine levels), HIQ.XPT (health insurance questionnaire), BPX.XPT (blood pressure 
measurements), HDL.XPT, TCHOL.XPT, TRIGLY.XPT and GHB.XPT (blood levels) 
were analyzed (NCHS 2013; NCHS, 2015; NCHS, 2017b). NHANES data have been 
utilized as secondary data sources for some descriptive and analytical research that 
include behavioral and chronic disease-related studies such as diabetes retinopathy 
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(Ahluwalia et al., 2017; Shah, 2016; Song et al., 2016; Zhang et al., 2010). The 2015-
2016 NHANES cycle dataset that was previously downloaded for the study did not yield 
sufficient study sample to meet the minimum study sample requirement of 308 obtained 
from a priori power analysis, this necessitated the acquisition of additional datasets from 
2011-2012 and 2013-2014 NHANES cycles. NHANES datasets are in the public domain 
like other data and materials created by federal agencies, which may be reproduced; there 
was no requirement for special permission for gaining access to them (CDC, 2017a).  
Study Sample Size: Power Analysis 
Performing sample size determination by power analysis requires effect size, 
desired Type I error rate (α) that is often set at p < .05, and the power, that is based on the 
desired Type II error rate, which is also conventionally set at 80% (Columb & Atkinson, 
2016; Faul et al., 2009). In using power analysis to determine the sample size for multiple 
regression analysis of the dataset for this research, the G*Power application was used 
(Faul et al., 2009). I selected z test as test family and logistic regression as the statistical 
test were selected. Power was set to .80, the desired Type I error rate (α) was set to .05; 
odds ratio at 1.5, and 2-tail hypothesis direction were selected based on the non-
directional hypothesis for this research. The minimum sample size of 308 for this 
research was calculated from an a priori power analysis utilizing G*POWER (Faul et al., 
2009). 
Instrument and Operationalization of Variables 
Data for 2011-2012, 2013-2014, and 2015-2016 NHANES cycles were from 
initial home interviews and health examination section of the study conducted in the 
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mobile examination center (NCHS, n.d.). Specific items and scales utilized from the 
combined 2011-2012, 2013-2014, and 2015-2016 NHANES datasets included 
DEMO.XPT (demographics), DIQ.XPT (diabetes questionnaire), BPQ.XPT (blood 
pressure and cholesterol questionnaire), ALB_CR.XPT (urine levels), HIQ.XPT (health 
insurance questionnaire), BPX.XPT (blood pressure measurements), HDL.XPT, 
TCHOL.XPT, TRIGLY.XPT and GHB.XPT (blood levels) were analyzed (NCHS 2013; 
NCHS, 2015; NCHS, 2017b).  I did not need any permission to use these datasets. The 
different datasets from particular NHANES cycle were merged, the final datasets from 
the three NHANES cycles were appended, and new data set peculiar to the study sample 
was created.  
To answer the research questions, there was a need to recode some of the 
variables that have been used by NHCS in the original data collection to new variables 
and merging of variables to form composite variables such as DM comorbidity and health 
care access. The new dataset contains some demographic variables such as age groups, 
marital status, gender, annual household income, and adult education level; health 
insurance coverage; diabetes affected eyes/had retinopathy; high blood pressure and high 
cholesterol; UACR and HBAIC level. The variables were arranged into diabetic 
retinopathy (dependent variable); DM comorbidities, gender, health care access 
(independent variables); and age groups, HBA1C level, UACR, marital status, household 
income, and education level (covariates). A complex sample plan for complex sample 
analysis was created. The complex sampling plan was developed to assure correct data 
weighting, considering the effect of oversampling of African Americans and some other 
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groups that would have resulted in samples that were no longer representative of the 
populations, with consequential inaccurate findings. The final dataset was stored.  
Diabetic retinopathy, the dependent variable utilized for this study was assessed 
by participants’ self-report of having been informed by a doctor that the eyes were 
affected by diabetes; the level of measurement is binomial categorical. Assessment of 
DM comorbidities of hypertension and hyperlipidemia were through participants self-
report of being informed of by a health professional about having high blood pressure 
more than twice, an average systolic blood pressure at the medical examination center 
(MEC) of ≥130mmhg, and self-report of current use of medications for high cholesterol 
and low blood HDL level at the MEC; level of measurement is binomial categorical 
(American Heart Association (2019; U.S. National Library of Medicine [NIH], 2018). 
Gender is assessed through a self-report of being female or male; binomial categorical. 
Health care access was assessed by combining covered by health insurance, seeing a 
regular doctor for diabetes, last time had pupils dilated for exams variables into one 
variable with a binomial categorical level of measurement. 
Covariate of age groups was assessed by self-report of age in years at screening, 
the age groups are as advised by NCHS; it is an ordinal categorical variable (NCHS, 
2018). HBA1C level was assessed by the participants HBA1C level, a continuous level of 
measurement (ADA, 2018; Garber et al., 2018). Assessment of participants’ UACR was 
by the participants’ UACR levels, a continuous level of measurement (ADA, 2018). 
Marital status is a binomial categorical variable. Annual household income and education 
level variables are ordinal categorical. For complex sample analysis, variables that 
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identified the sample strata, sample clusters, and sample weight are included. The 
following table shows the operationalization of study dependent and main independent 
variables, covariates, and complex sample parameters 
Table 1 
 
Operationalization of Study Independent, Dependent, and Covariate Variables 











































1. Ever told you had 
high blood pressure 2+ 
times 
2. Systolic hypertension 
3. Now taking meds for 
high cholesterol 
4. Low HDL 
 
Age in 20-39; 40-59; 






1. Covered by health 
insurance 
2. Has a regular doctor 
for diabetes 
3. Last time had pupils 








Blood HBAIC level % 
 
 





0 = No. 1 = Yes 
 
 
0 = No DM comorbidity  







1 = 20-39 years 
2 = 40-59 years 
3 = 60 years and over 
 
0 = male 
1 = female 
 
0 Did not have health 
care access 















1 = Less than high 
school 
2 = High school Grad/ 






































































































4 = College graduate 
or above 
1 Married 
2 Divorced, widowed, 
and separated 
3 Never married and 
living with a partner 
 
0 = Refused, Don’t 
know, Missing 
1 = less than $20,000 
2 = $20,000-$44,999 
3 = $45,000-$74,999 
4 = $75,000-$99,999 
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Data analysis was conducted with SPSS (Version 25). I downloaded datasets from 
2011-2012, 2013-2014, and 2015-2016 NHANES cycles, such as DEMO.XPT 
(demographics), DIQ.XPT (diabetes questionnaire), BPQ.XPT (blood pressure and 
cholesterol questionnaire), ALB_CR.XPT (urine levels), HIQ.XPT (health insurance 
questionnaire), BPX.XPT (blood pressure measurements), HDL.XPT, TCHOL.XPT, 
TRIGLY.XPT and GHB.XPT (blood levels) (NCHS 2013; NCHS, 2015; NCHS, 2017b). 
To answer the research questions, some variables previously used by NCHS in the 
original data collection were transformed into new variables, including composite 
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variables. Final variables for this study are mostly categorical with two continuous 
variables (HBAIC and UACR). Individual files from each NHANES cycle were merged 
into datasets for the respective cycles that were then appended to form a final dataset for 
2011-2012, 2013-2014, and 2015-2016 NHANES cycles. A new dataset peculiar to the 
study sample of African Americans, 20 years and over, with a self-reported diagnosis of 
DM was subsequently created. The final dataset was then prepared for analysis. 
A complex sampling plan was developed to assure correct data weighting that 
should lead to accurate findings, considering the effect of oversampling of African 
Americans and some other groups that would have resulted in samples that were no 
longer representative of the populations with consequential inaccurate findings (NCHS, 
2018). Missing values were managed by listwise default deletion function of SPSS that 
automatically drops a missing case from analysis instead of its deletion from the dataset; 
it is automatically applied with logistic regression analysis in SPSS irrespective of any 
previous data cleaning method (IBM, 2016). In preventing the introduction of bias to 
estimates such as mean values with resultant misestimated values, handling outliers is 
important prior to data set analysis (Kwak & Kim, 2017). Identified outliers by an outlier 
detection function in binary logistics for glycohemoglobin and urine albumin-creatinine 
ratios were less than 5% of values of the two variables (Kwak & Kim, 2017; Sindhumol, 
Gallo, & Scrinivasan, 2017). High collinearity presence in a multiple linear or logistic 
regression model may result from predictors’ high variances leading to inaccurate 
estimations, which can evoke doubts about the results of the analysis (Salmerón, García, 
& García, 2018). As such, collinearity detection by a variance inflation factor (VIF) and 
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tolerance is a necessary initial step compulsory first step in every multiple regression 
analysis (Salmerón et al., 2018). A variance inflation factor value of less than 10 or 
tolerance value greater than 0.1 is accepted as the absence of collinearity in a multiple 
regression model (Salmerón et al., 2018). Absence of extreme collinearity within the 
independent variables for this study was asserted with variance inflation factor values of 
less than 10 (see Table 7).  
 I conducted preliminary descriptive statistics. Frequencies and percentages were 
calculated for the categorical variables, and minimum and maximum scores, means, and 




Descriptive Analysis Plan for Dependent and Independent Variables, and Covariates 
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Research Questions and Hypothesis 
The following research questions and hypothesis were addressed in this study: 
RQ1: Is there an association between gender and diabetes retinopathy among 
adult African Americans in the United States? 
Hо1: There is no association between gender and diabetes retinopathy among 
adult African Americans in the United States 
 H₁1: There is an association between gender and diabetes retinopathy among 
adult African Americans in the United States. 
RQ2: Is there an association between DM-related comorbidities of hypertension, 
hyperlipidemia, and diabetic retinopathy among adult African American populations in 
the United States? 
 Hо2: There is no association between DM-related comorbidities of hypertension, 
hyperlipidemia, and diabetic retinopathy among adult African American populations in 
the United States. 
H₁2: There is an association between DM-related comorbidities of hypertension, 
hyperlipidemia, and diabetic retinopathy among adult African American populations in 
the United States. 
  RQ3: Is there an association between health care access and diabetic retinopathy 
among adult African Americans in the United States?   
 Hо3: There is no association between health care access and diabetic retinopathy 
among adult African Americans with DM in the United States. 
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 H₁3: There is an association between health care access and diabetic retinopathy 
among adult African Americans with DM in the United States. 
Level of significance (α) = 0.05. 
Statistical Tests and Interpretation of Results 
Sample characteristics were described with descriptive statistics.  Percentages or 
proportions are for the categorical independent and dependent variables, and minimum 
and maximum scores, means, and standard deviations were computed for the continuous 
variables. The dependent variable (diabetic retinopathy) in this study is dichotomous, as 
such the relationships between diabetic retinopathy and the independent variables for this 
study can be examined by logistic regression (Ranganathan, Pramesh, &Aggarwal, 2017).  
Three logistic regressions were conducted to examine (a) the association between gender 
and diabetic retinopathy among adult African Americans in the United States; covariates 
include age groups, HBA1C level, UACR, marital status, adult education level, and 
annual household income; (b) the association between DM comorbidities of hypertension 
and hyperlipidemia and diabetic retinopathy among adult African American populations 
in the United States; covariates are age groups, HBA1C level, UACR, marital status, 
adult education level, and annual household income; and (c) association between health 
care access and diabetic retinopathy among adult African-Americans in the United States; 
covariates are age groups, HBA1C level, UACR, marital status, adult education level, and 
annual household income. These chosen covariates have been reported as risk factors for 
diabetic retinopathy in various studies on risk factors for diabetic retinopathy in various 
ethnic/racial populations, including adult African-American populations. 
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For statistical analysis, the independent variables and the covariates were included 
in all models; the results might have shown any significant relationship between gender 
and diabetic retinopathy in model 1, between DM comorbidities of hypertension and 
hyperlipidemia and diabetic retinopathy in model 2, and between health care access and 
diabetic retinopathy in model 3, after controlling for HBAIC level, age group, UACR, 
marital status, adult education level, and annual household income. Results of logistic 
regression analysis were interpreted as odds ratios, the associated confidence intervals, 
and p-values (Sperandei, 2014). Interpretation formats for both dependent and 
independent variables are shown in Table 3. 
Table 3 
Plan for statistical analysis 
Variables Statistical analysis method Interpretation of results 
Model 1 Multiple logistic regression 
analysis 
Odds ratios, the associated 
confidence intervals, and 
p values 
Model 2 Multiple logistic regression 
analysis 
Odds ratios, the associated 
confidence intervals, and 
p values 
Model 3 Multiple logistic regression 
analysis 
Odds ratio, the associated 
confidence intervals, and 
p values 
 
There are assumptions to be met to ensure the accuracy of statistical findings of 
logistic regression analysis; these assumptions are different from those of multiple linear 
regression analysis in some areas (McDonald, 2014; Sperandei, 2014). For example, 
linear relationship between the dependent and independent variables is not required, 
residuals are not required to be normally distributed, and there is no requirement for 
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homoscedasticity (McDonald, 2014; Sperandei, 2014). However, assumptions associated 
with logistic regression include correct specification of the logistic regression model, 
specified absence of multicollinearity absence, inclusion of all relevant predictors, and 
large sample size (McDonald, 2014; Pituch & Stevens, 2016; Sperandei, 2014).   
From the omnibus test of model coefficients table and the Nagelkerke R2 from the 
model summary table, the overall model was significant (Pituch & Stevens, 2016) The 
individual predictors are relevant based on p values of .000 (< 0.05), the Wald test, and 
the EXP(B) (odds ratio) (Pituch & Stevens, 2016). Absence of collinearity within the 
independent variables for this study was determined with VIF values of less than 10 (see 
Table 7). According to Long (1997), for logistic regression, sample size larger than 500 is 
sufficient (Long, 1997). The sample size for this study (634) is adequate (see Long, 
1997).   
Threats to Validity 
The main aim of NHANES is the production of a wide range of health and 
nutrition statistics based on age, gender, and race composition of the United States 
population (NCHS, 2017). All secondary data that include NHANES data requires a 
thorough assessment of not only the results but also rigors of the studies by assessment of 
data collection methods through measurement of validity and reliability measurement of 
instruments (Mohajan, 2017). Validity is the extent to which a concept is accurately 
measured in a quantitative study (Mohajan, 2017; Salimi & Ferguson‐Pell, 2017). Types 
of validity include internal validity that refers to whether the observed effects on the 
dependent variable are related to the independent variables and not due to confounding 
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variables; external validity, which is the extent the results can be generated beyond the 
study population; and construct validity that refers to how well the research instrument 
measures the constructs being studied  (Mohajan, 2017; Salimi & Ferguson‐Pell, 2017).  
Threats to external validity affect the generalization of the study results beyond 
the study population, which in the NHANES, may be significant because of the 
oversampling of specific subgroups such as the African-Americans that could have 
resulted in response rate bias, the study result may not be representative of the general 
population (Meterko et al., 2017). The large sample used for the NHANES could have 
reduced the generalizability threat of the study results. Threats to internal validity include 
research factors, which have not been accounted for the effect on the outcome variables 
such as confound bias and reverse causation in correlational studies;  self-reporting that 
can lead to recall bias due to inaccurate or incomplete recollections of past events or 
experiences, and reporting bias, which could arise from study participants prior 
knowledge of participation and the process involved, leading to suppression of 
information that may be deemed not to be socially acceptable (Salimi & Ferguson-Pell, 
2017). Internal validity was minimized in 2011-2012, 2013-2014, and 2015-2016 
NHANES cycles with the multistage probability sampling technique that was used.  
Confounding occurs when the observed effect on the dependent variable is related to the 
independent variable(s) and another factor that is independently associated with both 
dependent and independent variables, this can be corrected by covariate analysis (Salimi 
& Ferguson-Pell, 2017). The threat to construct validity may be due to the poor 
operationalization of study constructs, which for NHANES may be minimal because of 
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previous repeated use of the measurement instruments (Pierannunzi, Hu, & Balluz, 2013; 
Salimi & Ferguson-Pell, 2017). In a cross-sectional study, reverse causation is due to the 
inability to define the temporal precedence of variables (Salimi & Ferguson-Pell, 2017).  
Ethical Procedures 
This study utilized secondary data using de-identified data from 2011-2012, 2013-
2014, and 2015-2016 cycles datasets such as DEMO.XPT, DIQ.XPT, BPQ.XPT, 
HIQ.XPT, BPX.XPT, HDL.XPT, TCHOL.XPT, TRIGLY.XPT and GHB.XPT (NCHS 
2013; NCHS, 2015; NCHS, 2017b). 
I did not need any permission to use these datasets, and I did not need to obtain 
permission from NCHS before acquiring the dataset. The datasets were acquired upon 
obtaining the required Walden University Institutional Board (IRB) approvals before 
accessing the datasets for analysis. The IRB approval number is 03-26-19-0397499 
Ethical guidelines for the protection of human subjects that must have been 
followed by NCHS included: the approval of the original request for new protocol #2011-
17 by the NCHS review board; review process was utilized by NHANES; data collection 
was protected by public law (45 CFR 46); and participant consent was approved and 
documented by the NCHS review board before the commencement of the study (NCHS, 
2017f; Office for Human Research Protections. 2016). Verbal consent was provided by 
the primary study participants for 2011-2012, 2013-2014, and 2015-2016 NHANES 
during the process of recruitment, and data were subsequently anonymized (NCHS, n.d). 
2011-2012, 2013-2014, and 2015-2016 NHANES datasets do not contain any 
identification of study participants. Upon obtaining IRB approval from Walden 
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University, the four datasets will be downloaded from the NCHS site and saved in a 
separate jump drive secured in my workbag and will only be accessed as needed for my 
doctoral study alone. The datasets and all related files will be kept in my home safe and 
destroyed later.  
Summary 
In this chapter, I provided a detailed discussion of the research design and data 
collection for my study on the association between gender, DM comorbidity, health care 
access, and diabetic retinopathy among adult African Americans. The chapter 
commenced with a discussion of the study research design and the rationale for its use, 
followed by an exhaustive discussion on methodology including study population and its 
size determined by a priori power analysis utilizing G*Power; sampling and sampling 
procedures utilized used in data collection for the 2011-2012, 2013-2014, and 2015-2016 
NHANES cycles, and the current research; study instrumentation and study variables 
operationalization; data analysis plan; threats to validity with particular reference to 
internal, external, and construct validity; and ethical considerations. In the next section, I 




Section 3: Presentation of the Results and Findings 
Introduction 
This research is aimed at examining associations between health utilization 
factors of gender, DM comorbidities of hypertension and cholesterol, and health care 
access, and diabetic retinopathy among adult African Americans. In this section, after 
describing the data collection method for the 2011-2012, 2013-2014, and 2015-2016 
NHANES cycles data, I present the results and findings from data analysis using SPSS 
(Version 25). Discourse on results encompasses descriptive statistics on study 
participants, evaluation of statistical assumptions as appropriate to the study, report on 
statistical analysis findings organized by research questions and hypotheses, and report 
on results of posthoc analyses of statistical tests, as applicable.  
Data Collection Method of 2011-2016 NHANES Data 
For this study, I used data from a nationally representative combined dataset of 
2011-2012, 2013-2014, and 2015-2016 NHANES cycles. NHANES uses complex, 
multistage probability design with a large sample to assure reliability and precision of the 
health status of the target population and selected sample (CDC/NCHS, 2017a). Upon 
obtaining IRB approvals, I downloaded individual datasets for each of the three cycles 
(see NCHS 2013; NCHS, 2015; NCHS, 2017b ) such as DEMO.XPT (demographics), 
DIQ.XPT (diabetes questionnaire), BPQ.XPT (blood pressure and cholesterol 
questionnaire), ALB_CR.XPT (urine levels), HIQ.XPT (health insurance questionnaire), 
BPX.XPT (blood pressure measurements), HDL.XPT, TCHOL.XPT, TRIGLY.XPT and 
GHB.XPT (blood levels). Acquiring the three combined datasets was necessary to obtain 
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a large sample of 500 or more participants for logistics regression analysis for this study 
(see Long, 1997).  
I merged the individual datasets for each respective year by participant sequence 
number and subset to include only observations pertinent to this research to form a 
dataset for the year. The resulting three datasets were appended to create a combined 
dataset that I sorted based on variables of the African American race, age 20 years and 
over, and DM. The number of sampled individuals for the 2011-2012, 2013-2014, and 
2015-2016 NHANES cycles was 43,090; of these participants, 29,902 (69%) had been 
interviewed, and 28,695 (66.6%) had been examined (NCHS, 2013, 2015, 2017). There 
were 7121 (18.2%) African Americans interviewed, 3809 (52.8%) of whom were 20 
years of age or older, and 634 (8.9%) of whom were 20 years of age or older with self-
report of diabetes diagnosis (NCHS, 2013, 2015, 2017). 
To answer the research questions, I transformed some of the variables that have 
been used by NHCS in the original data collection into new variables, including 
composite variables (diabetes comorbidity and health care access). Final variables for this 
study were predominantly categorical, except for two continuous variables (HBA1C 
levels and UACR). A complex sampling plan was developed to assure correct data 
weighting that should lead to accurate findings, considering the effect of oversampling of 
African-Americans and some other groups that would have resulted in samples that were 
no longer representative of the populations, with consequential inaccurate findings and 
poor generalizability (see NCHS, 2018). 
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Using SPSS (Version 25), I performed descriptive and inferential data analysis of 
the final dataset utilizing the created complex sample plan developed to assure correct 
data weighting and national representativeness of the findings. 
Independent categorical variables are automatically dummy coded by SPSS in 
logistic regression, with 0 as a reference factor. I obtained weighted and unweighted 
frequencies and percentages for the categorical independent variables and the dependent 
variables, as well as mean, standard deviation, minimum, and maximum scores for the 
continuous variables of HBAIC and UACR.  
Results 
Descriptive Statistics of Demographic and Baseline Study Variables 
The final dataset consisted of 634 African Americans age 20 years or older with 
self-report of diabetes (n = 634); average age was 58.96 years (SD = 12.875). Males were 
52.7% of the study sample, and married participants were 40%. The proportion of study 
sample in the age group 60 years and over was 62.1%. Over half of the study sample 
(63.2%) reported annual household income of less than $50,000, and the proportion of 
study participants with at least some college education or higher was 66.4%. Table 4 
illustrates dependent and independent variables for this study, with unweighted and 
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Descriptive statistics for continuous pertinent baseline and independent variables 
are shown in Table 5. The average HBAIC level was 7.5% (SD = 2.11) and UACR was 
232.00 mg/g (SD = 687.14). Average systolic blood pressure was 134 mmhg (SD = 
20.67) and diastolic blood pressure was 69 mmhg (SD= 16.44). Average total cholesterol 
was 181.46 mg/dl (SD = 48.72), HDL cholesterol was 51.3 mg/dl (SD =15.49), and LDL 
was 102.64 mg/dl (SD = 39.04). 
Table 5 
Descriptive Statistics for Continuous Pertinent Baseline and Independent Study 
Variables 
  Minimum Maximum M SD 
HBA1C (%)  4.60 17.80 7.52 2.11 
UACR (mg/g)  1.91 5928.00 232.00 687.14 
Systolic blood pressure (mmHg)  86 190 134 20.667 
Diastolic blood pressure (mmHg)  0 110 69.80 16.493 
Total cholesterol (mg/dl)  75 389 181.46 48.723 
Direct HDL-Cholesterol (mg/dl)  22 156 51.43 15.489 
LDL-Cholesterol (mg/dl)  15 240 102.64 39.040 
 
 
Table 6 depicts the unweighted and weighted frequencies and percentages for the 
composite independent categorical variables’ factors. For example, for health care access, 
89.6% of study participants reported having health insurance coverage, 80.0% reported 
having a regular diabetes doctor, and 76.8% reported having had recommended dilated 
eye examination. For diabetic comorbidities, about 68.5% reported being informed that 
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they had high blood pressure twice and 35.7% had systolic high blood pressure recorded; 
current use of cholesterol medications was reported in about 55.25%, and 18.5% had low 
HDL blood measurement.  
Table 6 
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Three research questions and hypothesis were addressed in this study. The 
dependent variable of diabetic retinopathy was a binary response variable. Complex 
samples logistic regression was conducted due to the absence of complex samples binary 
logistic regression option in SPSS. Assumptions associated with logistic regression such 
as the correct specification of the logistic regression model, the inclusion of all relevant 
predictors, large sample size, and absence of multicollinearity were met (McDonald, 
2014; Pituch & Stevens, 2016; Sperandei, 2014). Absence of multicollinearity was 
assured with the variance inflation factor (VIF) values of the independent variables that 
were less than 10, as shown in Table 7.  
Table 7 
Variance Inflation Factor Values for Independent Variables and Covariates 
Variables VIF* 
Urine albumin-creatinine ratio 1.067 
Marital status 1.246 
Age groups 1.248 
Annual household income 1.439 
Diabetes comorbidity 1.046 
Health care access 1.551 
Adult education level 1.164 
Gender 1.128 
HBAIC 1.128 




I conducted a two-step complex samples logistic regression analysis to answer 
each research question (see Sperandei, 2014). The first step was a model to investigate 
the relationship between the main predictor variable and the dependent variable of 
diabetic retinopathy; it served as a comparison model (Sperandei, 2014). The second step 
was a full model to determine the strength of the effect of multiple independent variables 
(main independent variables and covariates) on the dependent variable (see Sperandei, 
2014).   
Research Question 1 
Is there an association between gender and diabetes retinopathy among adult 
African Americans in the United States? 
Hо1: There is no association between gender and diabetes retinopathy among 
adult African Americans in the United States. 
H₁1: There is an association between gender and diabetes retinopathy among adult 
African Americans in the United States. 
α = .05 
To address this question, a two-step complex samples logistic regression analysis 
was conducted (see Sperandei, 2014). The first step of the regression analysis was a 
reduced model with the predictor variable of gender and the dependent variable of 
diabetic retinopathy. From the default predicted versus observed classification table in 
SPSS, this regression model correctly classified participants 80.1% of the time. The 
overall model for this step was not significant, x² (1) = 3.795, p = .063, Nagelkerke R² = 
.006. The null hypothesis that there was no association between gender and diabetes 
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retinopathy among adult African American populations in the United States was not 
rejected. This model functioned as the model for comparison. 
The second step of logistic regression analysis was full a full model with the 
predictor variable of gender, the dependent variable of diabetic retinopathy, and all 
covariates of age groups, HBA1C level, UACR, marital status, education level, and 
annual household income. This model correctly classified participants 81.2% of the time; 
a statistically significant improvement over the comparison model was provided, x² (7) = 
134.113, p < .001, Nagelkerke R² = .141. UACR, annual household income, and adult 
education level were statistically significant. The null hypothesis that there was no 
association between the combined predictor variables of gender and the covariates and 
diabetic retinopathy among adult African American populations in the United States was 
rejected. 
However, gender, the main variable of interest was not significant in the two 
models (p = .063 and .271); the null hypothesis for Research Question 2 was not rejected. 
Table 8 displays the results of the comparison and full models for the logistic regression 
















95% CI for OR 
     Lower                   Upper 
1 
2 
Gender 3.80 .063 0.73 0.53                        1.02  
Gender (ref: Male) 1.28 .271 0.76 0.45                         1.27  
HBAIC 0.01 .919 1.00 0.93                          1.07  
Urine Albumin-Creatinine Ratio 107.34 .000 1.03 1.01                          1.04  
Marital Status (ref: Married) 0.25 .623 0.90 0.65                           1.30  
Annual Household Income (ref: 
Less than $20,000) 
17.31 .000 1.15 1.07                         1.24  
Age Groups (ref: 60-80 years 
old) 
3.51 .075 0.73 0.51                           1.04  
Adult Education Level (ref: Less 
than High school Education) 




Research Question 2 
Is there an association between DM-related comorbidities of hypertension, 
hyperlipidemia, and diabetic retinopathy among adult African American populations in 
the United States? 
 Hо2: There is no association between DM-related comorbidities of hypertension, 
hyperlipidemia, and diabetic retinopathy among adult African American populations in 
the United States. 
 H₁2: There is an association between DM-related comorbidities of hypertension, 
hyperlipidemia, and diabetic retinopathy among adult African American populations in 
the United States. 
α = .05 
To address this question, a two-step complex samples logistic regression analysis 
was conducted (Sperandei, 2014). The first step of the regression model was a reduced 
model with the predictor variable of DM comorbidities and the dependent variable of 
diabetic retinopathy. From the default predicted versus observed classification table in 
SPSS, this regression model correctly classified participants 80.1% of the time. The 
overall model for this step was not significant, x² (1) = 1.505, p < .232, Nagelkerke R² = 
.001. The null hypothesis that there was no association between DM comorbidities of 
hypertension, hyperlipidemia, and diabetic retinopathy among adult African American 




The second step of the logistic regression model was full a full model with the 
predictor variable of DM comorbidities, the dependent variable of diabetic retinopathy, 
and all covariates of age groups, HBA1C level, UACR, marital status, education level, 
and annual household income. UACR and annual household income were statistically 
significant. This model correctly classified participants 81.2% of the time; a statistically 
significant improvement over the comparison model was provided, x² (7) = 131.769, p < 
.001, Nagelkerke R² = .141. The null hypothesis that there was no association between 
the combined predictor variables of DM comorbidity and covariates and diabetic 
retinopathy among adult African American populations in the United States was rejected.  
However, DM comorbidity, the main variable of interest was not significant (p = 
.232 and .098); the null hypothesis for Research Question 1 was not rejected. Table 9 
displays the results of the comparison and full models for the logistic regression for the 

















95% CI for OR 
Lower               Upper 
1 
2 
Diabetic comorbidity 31.55 .232 1.30 0.95                   1.78  
Diabetic comorbidity (ref: No 
comorbidity) 
3.00 .098 1.30 0.95                   1.78  
HBAIC 0.02 .905 1.00 0.93                   1.06  
Urine Albumin-Creatinine Ratio 108.54 .000 1.02 1.00                   1.04  
Marital Status (ref: Married) 0.12 .734 0.99 0.67                  1.32  
Annual Household Income (ref: 
Less than $20,000) 
12.38 .002 1.13 1.05                   1.23  
Age Groups (ref: 60-80 years 
old) 
3.47 .077 0.73 0.51                   1.04  
Adult Education Level (ref: Less 
than High school Education) 






Research Question 3 
Is there an association between health care access and diabetic retinopathy among 
adult African Americans in the United States?   
 Hо3: There is no association between health care access and diabetic retinopathy 
among adult African Americans with DM in the United States. 
H₁3: There is an association between health care access and diabetic retinopathy 
among adult African Americans with DM in the United States. 
α = .05 
To address this question, a two-step complex samples logistic regression analysis 
was conducted (Sperandei, 2014). The first step of the regression analysis was a reduced 
model with the predictor variable of health care access and the dependent variable of 
diabetic retinopathy. From the default predicted versus observed classification table in 
SPSS, this regression model correctly classified participants 80.1% of the time. The 
overall model for this step was not significant, x² (1) = 1.929, p = .178, Nagelkerke R² = 
.010. The null hypothesis that there was no association between health care access and 
diabetic retinopathy among adult African American populations in the United States was 
not rejected. This model functioned as the model for comparison.  
The second step of logistic regression analysis was full a full model with the 
predictor variable of health care access, the dependent variable of diabetic retinopathy, 
and all covariates of age groups, HBA1C level, UACR, marital status, education level, 
and annual household income. This model correctly classified participants 81.0% of the 
time; a statistically significant improvement over the comparison model was provided, x² 
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(7) = 134.69, p <.001, Nagelkerke R² = .148. UACR and annual household income were 
statistically significant. The null hypothesis that there was no association between the 
combined predictor variables of health care access and the covariates and diabetic 
retinopathy among adult African American populations in the United States was rejected.  
However, health care access, the main variable of interest was not significant (p = 
.178 and .177); the null hypothesis for Research Question 3 was not rejected. Table 10 
displays the results of the comparison and full models for the logistic regression for the 


















95% CI   for OR 
Lower                   Upper 
1 
2 
Health care Access 1.93 .178 0.35 0.73                       1.67  
Health Care Access (ref: No 
health care access) 
1.96 .177 0.23 0.03                       2.06  
HBAIC 0.00 .992 1.00 0.93                       1.07  
Urine Albumin-Creatinine Ratio 111.05 .000 1.03 1.01                       1.04  
Marital Status (ref: Married) 0.05 .828 0.97 0.70                       1.34  
Annual Household Income (ref: 
Less than $20,000) 
15.00 .001 1.15 1.07                       1.23  
Age Groups (ref: 60-80 years 
old) 
2.75 .112 0.75 0.52                       1.08  
Adult Education Level (ref: Less 
than High school Education) 






There were three two-step complex samples logistic regression (reduced and 
saturated models) conducted to address the three research questions. Null hypotheses for 
Research Questions 1, 2, and 3 were not rejected because of the main predictor variables 
of DM comorbidity of hypertension and hyperlipidemia, gender, and health care access, 
respectively, were not significant. Covariates of UACR, annual household income, and 
adult education level were statistically significant in Model 1; UACR and annual 
household income were statistically significant in Models 2 and 3.  
 In the next section, I will discuss the implications of the results relative to similar 
studies or publications. There will also be discussions on recommendations for the 
professional practice among public health professionals, advocates, policymakers, and 
clinicians, which should result in a positive social change with the reduction of physical, 




Section 4: Application to Professional Practice and Implications for Social Change 
Introduction 
The purpose of this research was to examine associations between health 
utilization factors of gender, DM comorbidities of hypertension and cholesterol, health 
care access, and diabetic retinopathy among adult African Americans. In this section, the 
research findings will be interpreted; I will also discuss the study limitations; 
recommendations for the professional practice among clinicians and public health 
professionals, advocates, and policymakers; implications for professional practice and 
social change. The section ends with a conclusion. Data analyzed for this research were 
from a nationally representative combined dataset of 2011-2012, 2013-2014, and 2015-
2016 NHANES cycles. Descriptive and inferential data analysis of the final dataset was 
performed with SPSS (Version 25), using the complex sample plan I developed to assure 
correct data weighting that should lead to accurate findings representative of adult 
African American population in the United States.  
This study revealed a diabetic retinopathy prevalence of 21.5 % among the study 
participants. Albuminuria, annual household income, and education level were 
significantly associated with diabetic retinopathy.  
Interpretation of the Findings 
Prevalence of Diabetic Retinopathy 
Diabetic retinopathy is the dependent variable for this study. More than one fifth 
(21.5%) of the study participants and almost one fifth (19.5%) of study participants who 
were 40 years and older were affected by diabetic retinopathy. Males (22.6%) were 
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affected a little more than females (17.6%) (OR = 0.73 CL, 0.53 – 1.019). The overall 
prevalence was lower than the result of previous research involving African Americans 
For example, results of Zhang et al.’s (2010) cross-sectional study using data on a similar 
population from the 2005-2008 NHANES cycles, showed almost two-fifths (38.8%, p = 
.01) of African Americans had diabetic retinopathy. However, diabetic retinopathy was 
diagnosed from ophthalmic digital images (fundus photographs) of participants taken for 
the NHANES 2005–2008 cycles (Zhang et al., 2010).   
Results of the current research suggested a decline in the prevalence of self-
reported diabetic retinopathy, which is consistent with results of previous studies that 
have shown a declining trend in the prevalence of self-reported diabetic retinopathy. For 
example, Shah (2016), from a cross-sectional analysis of data from the NHANES 2011–
2012 and 2013–2014 cycles reported a decline in the prevalence of self-reported diabetic 
retinopathy among U.S. adults, 40 years old and over, with a rate of 14.7% (95% CI, 
11.7–17.8%). This represents a decline of 24.1% from the prevalence of 38.8% reported 
by Zhang et al. Luo et al. (2018) reported a significant decrease of 33% (trend p = .003) 
in the prevalence of self-reported diabetic retinopathy in North Carolina from 27.2% in 
2000 to 18.3% in 2015; a decrease from 21.7% to 17.6% in Whites (trend p = .04), and a 
decrease of 39.4% to 20.2% in African Americans (trend p = .002). Luo et al. used data 
from the behavioral risk factor surveillance system (BRFSS). According to Luo et al., 
even though a declining trend in the prevalence of self-reported diabetic retinopathy was 
observed, African Americans were still disproportionately affected.  
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Research Question 1 
Is there an association between gender and diabetes retinopathy among adult 
African Americans in the United States? 
The logistic regression models showed that the main independent variable, 
gender, was not significantly associated with diabetic retinopathy in African Americans. 
The result of this study is inconsistent with previous findings. However, after adjusting 
for covariates, urine albumin-creatinine ratio (p < .001), annual household income (p = 
.002), and adult education level (p < .048) were independently associated with diabetic 
retinopathy in adult African Americans.  
Results of the present study revealed that males (22.6%) were affected a little 
more than females (17.6%; OR = 0.73 CL .53 – 1.019). Previous studies have not 
established a consistent association between gender and development of diabetic 
retinopathy; and in the United States, there is no significant gender-related difference in 
the prevalence of diagnosed DM among adults (CDC, 2017; Ozawa et al., 2015; Wat et 
al., 2016). For example, Varma et al. (2007) reported that males had a 50% higher risk of 
having any diabetic retinopathy compared with women in the Los Angeles Latino eye 
study (OR = 1.50; p = .006). Although the results of Zhang et al.’ (2010) study on a 
representative sample of the U.S. population suggested that male gender is an 
independent risk factor for diabetic retinopathy, the prevalence was higher among Whites 
(59.7 %; 95% CI, 49.5%–69.1%) compared to African-Americans (24.0%; 95% Cl, 
18.2%–30.8%; p = .008). Abdulghani et al. (2018) reported an association between male 
gender and diabetic retinopathy in adult Saudi diabetic patients. However, results of a 
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prospective diabetes study 50 in the United Kingdom showed no difference in diabetic 
retinopathy rates between male and female sexes (p = 0.67), but it was a nonsignificant 
association (Stratton et al., 2001).  
Association between albuminuria and diabetic retinopathy in this study is 
consistent with previous studies, as discussed under Research Question 1. Also, the 
association between annual household income and education level, both components of 
SES, and diabetic retinopathy is consistent with previous findings (Bird et al., 2015; 
Emoto, Okajima, Sugihara, & Goto, 2016; Funakoshi et al., 2017; Hu et al.,2016; Kim et 
al., 2018; Lee, 2018; Tao et al., 2016). The results of the current research will be 
discussed in the last paragraph of this subsection because of their consistent relationship 
with diabetic retinopathy concerning the three research questions. 
Research Question 2 
Is there an association between DM comorbidities of hypertension, 
hyperlipidemia, and diabetic retinopathy among adult African American populations in 
the United States? 
The logistic regression showed no significant association between DM 
comorbidity of hypertension and hyperlipidemia, the main variable of interest, and 
diabetic retinopathy. However, after adjusting for covariates, UACR (p < .001) and 
annual household income (p = .002) were independently associated with diabetic 
retinopathy in African Americans. Research on the association between DM comorbidity 
of hypertension and hyperlipidemia in African American populations is scarce. However, 
the result of this present research is inconsistent with the findings of a previous study in 
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China by Cheng et al. (2014) that depicted a significant association between diabetic 
retinopathy prevalence and one, two, three, and four of the cardio-metabolites 
(hypertension, hypertriglyceridemia, HDL, and abdominal obesity) of 16.0%, 17.6%, 
21.3%, and 25.1%, (p = .001) respectively.  
The presence of modifiable DM comorbidities of hypertension and 
hyperlipidemia in individuals may not lead to complications. Hypertension exists when 
systolic blood pressure is greater than or equal to 140 mmHg or diastolic blood pressure 
is greater than or equal to 90 mmHg, or an individual is currently taking prescribed 
medicine to lower high blood pressure or told by a healthcare professional on two or 
more different visits that she/he had high blood pressure (American Heart Association, 
2019). Normal systolic pressure is 120mmhg or below, and normal diastolic blood 
pressure is 80mmhg or lower. Average total cholesterol level is less than 200mg/dL, LDL 
is less than 100mg/dL, and HDL is 40mg/dL or higher (U.S. National Library of 
Medicine [NIH], 2018). Hypertension and hyperlipidemia are fairly controlled among the 
study participants.  
Average measured systolic blood pressure of 134mmhg and HDL-cholesterol of 
51.43 mg/dL suggest fairly controlled hypertension and hyperlipidemia among the study 
participants. The nonsignificant association between diabetic retinopathy and diabetic 
comorbidity of hypertension and hyperlipidemia in this study could have been caused by 
the fairly controlled hypertension and hyperlipidemia among the study participants, 
which is consistent with previous research findings. For example, a Cochrane review by 
Do et al. (2015) showed that hypertension treatment could prevent diabetic retinopathy 
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but does not slow its progression, and results of a Danish study by Nielsen and 
Nordestgaard (2014) showed that use of statins before diagnosis of DM was associated 
with decreased rate of retinopathy development; its use was also linked to improvement 
in visual acuity in those with diagnosed diabetic retinopathy. 
Complications such as diabetic retinopathy arise when hypertension and 
hyperlipidemia are uncontrolled. Studies have shown that uncontrolled hypertension and 
hyperlipidemia although modifiable, are major intermediate factors underlying macro and 
microvascular disease such as diabetic retinopathy disparities of African American 
populations (Beckman & Creager, 2016; Lin et al., 2015; Magnan et al., 2015; 
Mozaffarian et al., 2016; Pantalone et al., 2015; Rosiek et al., 2016; Zhuo et al., 2014).  
Papavasileiou et al. (2017) and Penman et al. (2016) reported that diabetic retinopathy in 
African Americans is associated with longer duration of diabetes, uncontrolled 
hyperglycemia, and hypertension. Nonsignificant association between DM comorbidity 
of hypertension and hyperlipidemia may be related to their reasonably controlled levels. 
For example, this present study revealed that for the composite variable of DM 
comorbidity, 68.5% of study participants were informed they had high blood pressure 
twice, and systolic high blood pressure was recorded on 35.7% of them. However, 
average recorded systolic blood pressure was 134mmhg, and average diastolic pressure 
69.80 mmHg (see Tables 5 and 6). Likewise, for the composite variable of 
hyperlipidemia, 55.2% of participants reported taking cholesterol medications, and 18.5% 
of them had low HDL; yet average total cholesterol was 181.46 mg/dl, direct HDL 
cholesterol was 51.43 mg/dl, and LDL was 102.64 mg/dl (see Tables 5 and 6).   
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Albuminuria (proteinuria) is a recognized marker of nephropathy (kidney 
disease), and in patients with DM, it is a marker of diabetic nephropathy, which reflects 
microvascular complications of diabetes that include diabetic retinopathy (ADA, 2018). 
According to ADA, albuminuria can be detected by UACR screening in a spot urinalysis, 
and UACR of less than 30 mg/g Cr is accepted as normal. Average UACR in this study 
was 232.00 (SD = 687.14). Albuminuria and estimated glomerular filtration rate should 
be monitored regularly in diabetic patients for (a) timely diagnosis of diabetic 
nephropathy that may occur late in the course of DM, especially in individuals with Type 
1 diabetics, or might be present at the time of diagnosis of Type 2 DM; (b) monitoring 
diabetic nephropathy progression; and (c) detection of other kidney diseases such as acute 
kidney injury that might be imposed on diabetic nephropathy (ADA). There is a paucity 
of literature on the relationship between albuminuria and diabetic retinopathy among 
African Americans. 
The association between albuminuria and diabetic retinopathy in this study is 
consistent with previous studies globally (Ahmed, Elwali, Awadalla, & Almobarak, 
2017; Hammes et al., 2015; Jeng et al., 2016; Korlarsky et al., 2015; Lee et al., 2017; 
Park et al., 2015). The results will be discussed fully at the end of this subsection because 
of the consistency of the relationship between albuminuria and diabetic retinopathy 
across the three research questions. The association between annual household income, a 
component of SES, and nephropathy is also consistent with previous findings. Annual 
household income is a component of SES. Results from the United States and other parts 
of the world have also depicted the relationship between diabetic retinopathy and SES. 
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The results from the present study will be discussed in the last paragraph in this 
subsection because of their consistent relationship with diabetic retinopathy concerning 
the three research questions. 
Research Question 3 
Is there an association between health care access and diabetic retinopathy among 
adult African Americans in the United States?   
The logistic regression models showed that the main independent variable, health 
care access, was not significantly associated with diabetic retinopathy in African 
Americans. However, after adjusting for covariates, UACR (p < .001) and annual 
household income (p = .001), were independently associated with diabetic retinopathy 
among adult African Americans. The result that health care access is not associated with 
diabetic retinopathy is inconsistent with previous studies. For example, the results of 
several studies showed that health care access is crucial to achieving control of 
hyperglycemia, hypertension, and hyperlipidemia; early detection of diabetic retinopathy 
through regular eye-screening of DM patients; and prompt management of diabetic 
retinopathy that can prevent the development of early diabetic retinopathy and the 
progression to the late stages (Atchison & Barkmeier, 2016; Chen et al., 2014; Chew et 
al., 2014; Do et al., 2015; Lee et al., 2015; Lima et al., 2016; Mendanha et al., 2016; 
Romero-Aroca et al., 2016; Ting et al., 2016; Wat et al., 2016).  
Health care access involves getting into the health care system, which is 
commonly through medical insurance coverage, geographic accessibility of required 
health care services that include diabetes eye screening, and identifying a trustworthy 
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health care provider that can be easily communicated with (Chou et al., 2014; Do et al., 
2015; Lee et al., 2015; Mendanha et al., 2016; Romero-Aroca et al., 2016; Wat et al., 
2016). The present study revealed that only 39.2% of the study population had access to 
health care, lack of which could have affected their adequate management, including 
regular eye screening for diabetic retinopathy. Relationship between disparities in 
diabetes prevention services obtained and status of medical insurance during health care 
facility visit was depicted by results of a retrospective cohort research by Bailey et al. 
(2016); with lower odds (AOR=0.73, 95% CI = 0.66, 0.80) of receiving services at 
scheduled visits in those that were continuously insured, compared to the continuously 
uninsured patients. However, the internal and external validity of the results is 
compromised by the purposive sampling method used and a predominantly Hispanic 
population.  
Results of a prospective follow-up study by Hu et al. (2016) depicted that 
socioeconomic status is a stronger determinant of access to primary care and quality and 
outcomes in those with T2DM than race and ethnicity. Bird et al. (2015) reported that 
household income has a strong and independent association with the prevalence of T2DM 
and some concordant comorbidities; however, African Americans were not included in 
the study. Even though socioeconomic barriers were eliminated, there might be 
difficulties in identifying a trustworthy health care provider that can be easily 
communicated with, due to perceived racial discrimination. 
Quality of health care service and the ability to identify a trusted health care 
provider are related to racial health care discrimination. Racial and ethnic disparities exist 
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in quality of care provided for control of chronic noncommunicable diseases such as 
hypertension, hyperlipidemia, and diabetes that are risk factors for diabetic retinopathy, 
with African-Americans and other minority patients having suboptimal control for blood 
sugar, blood cholesterol, and blood pressure with resultant complications that include 
diabetic retinopathy (Agency for Healthcare Research and Quality, 2017; Laiteerapong et 
al., 2015; Yoon et al., 2015). According to Abramson et al. (2015), racial minorities, 
especially African-Americans reported more racial health care discrimination; and 
increased perceptions of discrimination were associated with poor communication with 
health care provider across all racial and ethnic groups, and perceptions of discrimination 
were associated with an increased level of education in all racial and ethnic groups except 
Whites. Laiteerapong et al. (2015) carried out a cross-sectional study on a nationally 
representative sample to determine disparities in diabetes care. The results showed that 
more Whites  achieved A1C < 8% goal than African Americans (81% versus 74%, p < 
.001); fewer African Americans were recommended individualized LDL goals compared 
to Whites (10% versus 33%, p < .003 ; more Whites (51%) achieved individualized LDL 
control; and adequate blood pressure control goal of less than 140/90 mmHg was reached 
by fewer African-Americans compared to Whites (53% versus 69% P < .001). Results of 
a cross-sectional study by Assari et al. (2017) demonstrated that racial health care 
discrimination is reported more by African American men with T2DM than women; and 
perceived discrimination is associated higher levels of HBA1C in African American men.  
Previous studies showed that even though African Americans are among those 
that are disproportionately affected by diabetic retinopathy, they had one of the lowest 
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rates of diabetic retinopathy screening and scheduled follow-up eye care utilization 
(Keenum et al., 2016; Maclennan et al., 2014; Yu et al., 2015). Results of a prospective 
follow-up study by Keenum et al. (2016) showed that despite minimizing accessibility 
and costs as barriers to eye care, only a third of study participants adhered to scheduled 
intervals for follow-up eye care after the diabetic retinopathy screening. 
Association between albuminuria and diabetic retinopathy in this study is 
consistent with previous studies, as discussed under research question 1. Also, the 
association between annual household (a component of SES) and nephropathy is 
consistent with previous findings. They are also consistent with findings in Research 
Questions 1 and 2. The relationship between annual household income alone and as a 
component of SES will be discussed in the last paragraph of this subsection.  
Associations Between Albuminuria, Annual Household Income, Education Level, 
and Diabetic Retinopathy in African Americans 
The association between albuminuria and diabetic retinopathy in this study is 
consistent across the three research questions in the current study and also with previous 
studies globally (Ahmed et al., 2017; Hammes et al., 2015; Jeng et al., 2016; Korlarsky et 
al., 2015; Lee et al., 2017; Park et al., 2015). For example, Lee et al. (2017) in South 
Korea from a cross-sectional study reported an independent association between UACR 
level and diabetic retinopathy and its severity in those with Type 2 DM. Results of a 
cross-sectional study in South Korea by Park et al. (2015), showed that there was a 
significant association between albuminuria and diabetic retinopathy and vision-
threatening diabetic retinopathy in Type 2 diabetics with chronic kidney disease (p < .001 
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and .043) respectively. Ahmed et al. (2017) in Sudan reported a significant association 
between diabetic nephropathy and diabetic retinopathy (p = .009).  
In Germany, microalbuminuria was independently associated with diabetic 
retinopathy, and the strongest predictors of severe retinopathy were micro- and 
macroalbuminuria and HbA1c (Hammes et al., 2015). Korlasky et al. (2014) in a 
retrospective study carried out in southern Israel reported a unidirectional association 
between diabetic nephropathy and diabetic retinopathy, with diabetic nephropathy 
preceding diabetic retinopathy (p < .001) and level of kidney damage was proportionate 
to the level of retinopathy. In Taiwan, Jeng et al. (2016) found that diabetic nephropathy 
was an independent risk factor for diabetic retinopathy development and progression (p < 
.001).  
Associations between annual household income and education level, both 
components of SES and nephropathy are consistent with previous findings. They are also 
consistent with findings across the three research questions for the current study. 
According to APA, SES refers to the social class of an individual or group that is 
generally assessed by combining income, education, and occupation level (American 
Psychological Association, 2019). SES creates health inequity and inequality, including 
diabetic retinopathy that disproportionately affects disadvantaged groups such as the 
African American population. Studies showed that even though African Americans are 
among those are disproportionately affected by diabetic retinopathy, rates of diabetic 
retinopathy screening and scheduled follow-up eye care utilization were lowest in this 
population, which are related to limited health care access influenced by factors that 
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include socioeconomic status (Hu et al., 2016; Keenum et al., 2016; Maclennan et al., 
2014; Piyasena et al., 2019; Yu et al., 2015).  
In South Korea, the odds of developing diabetic retinopathy is significantly 
decreased in men with highest household income (OR, 0.59; 95% CI, 0.37 - 0.95), while 
men in lower SES group had higher odds of developing diabetic retinopathy and poor 
metabolic control (Kim et al., 2018). In a cross-sectional study on Type 2 DM patients in 
China, Tao et al. (2016) reported that those with the least education were at higher risk 
for developing cardiovascular diseases such as diabetic retinopathy (p < .001) and 
cerebrovascular diseases (p < .001); the highest prevalence of diabetic retinopathy (p < 
.001), and diabetic neuropathy (p < .001) was among patients with the lowest income. 
Among adults 20 - 40 years old with T2DM in Japan, when compared to those with a 
higher SES, there were higher odds of developing retinopathy among junior high school 
graduates (OR1.91, 95% CI 1.09 - 3.34); patients on public assistance (OR 2.19, 95% CI 
1.20 - 3.95); patients without employment (OR 2.23, 95% CI 1.36 - 3.68); and patients 
with temporary employment (OR 1.72, 95% CI 1.03 - 2.86) after adjusting for covariates 
of gender, age, and BMI (Funakoshi et al., 2017). In South Korea, lower education level 
was associated with lower diabetic retinopathy screening (Lee, 2018). Emoto et al. (2016) 
reported that among individuals with poorly controlled Type 2 DM in Japan, there was a 
strong association between lower educational attainment and diabetic retinopathy, which 
is independent of the economic status.   
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Limitations of the Study 
This was a cross-sectional study that utilized data on a nationally representative 
sample of adult African Americans with diabetes to examine the association between 
diabetic retinopathy and diabetes comorbidities of hypertension and hyperlipidemia, 
gender, health care access, and covariates (UACR, annual household income, age, marital 
status, HBA1C, and education level). However, there are some limitations to the study. 
Study participants for NHANES were only noninstitutionalized legal residents in the 50 
states and the District of Colombia; as such the results of this research may not be 
generalizable to those that did not qualify for inclusion in the survey (CDC, 2017a). The 
prevalence of diabetic retinopathy in this study could have been inaccurate because it was 
based on data from self-reported diagnosis, which could have resulted in recall bias due 
to inaccurate or incomplete recollections of past events or experiences, thus affecting the 
prevalence. Also, self-reported diagnosis without fundus photography of participants in 
2011-2012, 2013-2014, and 2015-2016 NHANES cycles compared to 2005-2008 
NHANES cycle could have underestimated the prevalence of diabetic retinopathy in this 
study. 
As a cross-sectional study, the relationships between the dependent variable of 
diabetic retinopathy and the independent variables were examined in a specified 
population within a specific timeframe; the association between diabetic retinopathy and 
the identified risk factors of albuminuria, annual house income, and education level were 
demonstrated. There was no indication of the order of events, limiting inference of cause 
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and effect (Caruana et al., 2015; Mariani & Pego-Fernandes, 2014; Omair, 2015; Setia, 
2016).  
Recommendations 
This cross-sectional study examined the relationships between the dependent 
variable of diabetic retinopathy and the independent variables that were in a specified 
population with a specific timeframe. Risk factors for diabetic retinopathy such as 
albuminuria, annual house income, and education level were identified, but cause and 
effect from simple association could not be established from the type of study design that 
was utilized. There is a paucity of literature on studies that established the identified risk 
factors as causes of diabetic retinopathy in adult African Americans. I recommend that 
the associations identified in the present study should be studied rigorously by utilizing 
longitudinal study designs to establish cause and effect (Mariani & Pego-Fernandes, 
2014; Setia, 2016).  
Prevalence of diabetic retinopathy in this study was based on data from self-
reported diagnosis that could resulted in recall bias due to inaccurate or incomplete 
recollections of past events or experiences, which could have affected the prevalence. 
Self-reported diagnosis without fundus photography of participants in 2011-2012, 2013-
2014, and 2015-2016 NHANES cycles compared to 2005-2008 NHANES cycle could 
have underestimated the prevalence of diabetic retinopathy in this study. Prevalence of 
diabetic retinopathy in all adults in this study was 21.5% and 19.5% in those 40 years and 
older, similar to 14.7% reported by Luo et al. (2018), suggesting a decline in the 
prevalence of self-reported diabetic retinopathy. The prevalence is lower than the result 
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of similar research by Zhang et al. (2010) that utilized digital retinal imaging system to 
assess the retina, with a prevalence rate of 38.8% among adults 40 years. I recommend 
the use of fundus digital imaging system photographs in assessing the retina of future 
NHANES participants, thus eliminating the recall bias associated with a self-reported 
diagnosis of diabetic retinopathy (Katulanda, Ranasinghe, & Jayawardena, 2014). 
Implications for Professional Practice and Social Change 
In this cross-sectional study, albuminuria, annual household income, and 
education level were identified as risk factors for diabetic retinopathy. Albuminuria (need 
factor), education level (predisposing factor), and annual household income (health care 
access factor) were identified as risk factors for diabetic retinopathy that affects about 
one-fifth of adult African Americans. The Andersen model of health care utilization was 
the framework for the research. Diabetic retinopathy is a significant cause of preventable 
eye damage that includes blindness; each year, between 12,000 and 24,000 new cases of 
blindness are caused by diabetes retinopathy (Skaggs et al., 2017).  
The vision-threatening diabetic retinopathy, although a preventable complication 
of DM, is associated with disease, economic, health care system, and social burdens. 
Quality of life of persons with any degree of moderate or total visual loss is affected in 
many ways such as their psychological and physical well-being, their work and possible 
loss of earning power, social integration, independence, and greater need for quality 
health and social support that could be overwhelmed in disadvantaged communities that 
include some African American communities where such services barely exist 
(International Diabetes Federation, n.d.; Skaggs et al., 2017; Willis et al., 2017). Early 
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detection of diabetic retinopathy is crucial in preventing visual impairment; and 
progression of diabetic retinopathy has been dramatically reduced by timely medical and 
surgical treatments (Jani et al., 2017).  
Even though African Americans are among those disproportionately affected by 
diabetic retinopathy, rates of diabetic retinopathy screening and scheduled follow-up eye 
care utilization were lowest in this population, which are related to limited health care 
access influenced by factors that include socioeconomic status (Hu et al., 2016; Keenum 
et al., 2016; Maclennan et al., 2014; Piyasena et al., 2019; Yu et al., 2015). SES creates 
health inequity and inequality which can only be addressed by interventions that target 
the societal determinants of health, developed and implemented by considering the 
broader, proximal, population-focused determinants that influence health inequalities and 
inequities among African Americans (Gehlert et al, 2008; Thornton et al., 2016; U.S. 
Department of Health and Human Services, 2010; WHO, 2016).  
Positive social change can be affected in African American populations and other 
disadvantaged communities by public health officials, policymakers, and advocates by 
utilizing knowledge on the strong relationships between the health care utilization factors 
(need, predisposing, and enabling factors) and diabetic retinopathy in planning and 
developing effective public health interventions targeting these communities. This should 
result in a decreased burden of diabetic retinopathy on individuals, families and friends, 
health care systems, and social support systems among specific African American 
populations and other disadvantaged communities. Suggested policy interventions 
include quality housing and health services, elimination of health discrimination, 
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improvement in education, and reduction in income disparity in some African American 
populations and other disadvantaged communities (Thornton et al., 2016). 
Conclusion 
This study investigated the associations between DM comorbidities of 
hypertension and hyperlipidemia (need factor), gender (predisposing factor), health 
access (enabling factor), and diabetic retinopathy in adult African Americans. The results 
demonstrated that DM comorbidities, gender, and health care access were not 
significantly associated with diabetic retinopathy. However, albuminuria (need factor), 
education level (predisposing factor), and household income (enabling factor) were 
significantly associated with diabetic retinopathy. These variables may be central to 
future studies to determine cause and effect relationships between diabetic retinopathy 
and the determinants of health care utilization among adult African Americans with DM. 
The result of this study is consistent with those of previous studies, which 
depicted that albuminuria, annual household income, and education level are risk factors 
for diabetic retinopathy among different racial groups. As such, it is crucial to consider 
the need, predisposing, and enabling factors that determine health care utilization and 
detection of diabetic retinopathy when planning public health intervention policies 
targeting disadvantaged populations. 
Chronic diseases such as DM, hypertension, and hyperlipidemia are modifiable 
risk factors for developing macro- and microvascular diseases such as diabetic 
retinopathy and nephropathy with their often-burdensome end stages that 
disproportionately affect African Americans and other disadvantaged racial and ethnic 
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groups. The socioeconomic and health disparities can be reduced by public health 
advocates and policymakers developing policy interventions that address the 
socioeconomic drivers of health inequalities and inequities among African Americans 
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